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To my family and friends
To my love, who is both
(...)
There lies the port; the vessel puffs her sail;
There gloom the dark, broad seas. My
mariners,
Souls that have toil'd, and wrought, and thought with me,
That ever with a frolic welcome took
The thunder and the sunshine, and opposed
Free hearts, free foreheads,
you and I are old;
Old age hath yet his honor and his toil.
Death closes all; but something ere the end,
Some work of noble note, may yet be done,
Not unbecoming men that strove with Gods.
The lights begin to twinkle from the rocks;
The long day wanes; the slow moon climbs; the
Deep
Moans round with many voices.
(...)
Tho' much is taken, much abides; and tho'
We are not now that strength which in old days
Moved earth and heaven, that which we are, we are,
One equal temper of heroic hearts,
Made weak by time and fate, but strong in will
To strive, to seek, to find, and not to yield.
- Alfred Lord Tennyson, “Ulysses”
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Summary
The dopaminergic neurons of the ventral midbrain (mesDA neurons) form several
distinct sub-populations which are involved in emotional control, reward behavior and
motor control. In patients with the neurodegenerative disorder Parkinsons Disease
(PD), one of these groups, the dopaminergic neurons of the substantia nigra, pars
compacta (SNpc) gradually die. One focus of research has been to find an explanation
why the SNpc neurons are more vulnerable to cellular stress than other neuronal
populations. In engrailed mutant mice, the absence of the homebox transcription
factors engrailed 1 and engrailed 2 (En1 and 2) causes a cell-autonomous and gene-
dose dependent loss of mesDA neurons. Recently, my lab identified several genes
differentially expressed between wild-type and engrailed mutant mice. Analysis of
mouse mutants of one of the genes, the forkhead containing trancription factor 1,
Foxa1 (formerly HNF3α) showed no phenotype in regard to the mesDA neurons. As
it is well known that members of the Fox/HNF family of genes can compensate for
each other, the focus of research shifted to  one downstream target of Fox genes, the
expression of KATP channels in mesDA neurons. KATP channels consist of Sur1 or 2
and Kir6.1 or 6.2 subunits and link the metabolic state of a cell to its membrane
potential. The hypothesis was, that misregulation or impairment of these channels
may lead to an increased electrical activity of the mesDA cells, putting them under
heightened physiological stress which then may in turn cause cell death. Analysis of
both Sur1 and Kir6.2 mouse mutants showed no change in TH+ cell number, cell
density or density of axonal projections, thus a loss of functional KATP channels has
no effect on the survival of mesDA neurons. After Liss and colleagues found a
decreased cell loss when Kir6.2 mutant mesDA cells suffer a toxin insult, I revised
my hypothesis and postulated that the normal open-closed state of KATP channels
influences cellular survival when the cell is under oxidative stress. In this work, I
show that blocking KATP channels in vitro by pharmaceutical means has a positive
effect on cell survival when mesDA are under oxidative stress. Conversely, forced
activation of KATP channels under these conditions leads to an increased rate of cell
death. Furthermore, abolishment of KATP channel expression in En1-/+:En2-/- mice
leads to a complete rescue of the mesDA cell of the SNpc. This highlights the
importance of KATP channel function and may give a new direction in the
development of drugs targeting Parkinsons disease.
Summary
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Zusammenfassung
Die dopaminergen Neurone des ventralen Mittelhirn (mesDA) sind an der Kontrolle
von Emotionen, Belohnungserwartung und Motorfunktionen beteiligt. In Patienten
mit der neurodegenerativen Krankheit Morbus Parkinson sterben die dopaminergen
Neurone der Substantia Nigra, pars compacta, ab. Es ist unklar, warum die SNpc
Neurone gegenüber zellulärem Stress anfälliger sind als andere neuronale
Zellgruppen. In engrailed Maus Mutanten, verursacht die Abwesenheit der
Homeobox-Transkriptionsfaktoren engrailed-1 und engrailed-2 einen progressiven
Verlust der mesDA Neurone. Kürzlich identifizierte unser Labor zahlreiche Gene, die
zwischen engrailed Mutante und Wildtyp differentiell exprimiert werden. Die
Analyse des Gens Foxa1, eines “forkhead-containing”-Transkriptionsfaktors, zeigte
aber keinen Phänotyp im Bezug auf die mesDA Neurone. Da aber bekannt ist, dass
die Mitglieder der Fox-Familie füreinander kompensieren können, fokussierten wir
unser Interesse auf eines der down-stream Ziele der Fox Gene, die Regulation der
Expression von KATP Kanälen in mesDA Neuronen. KATP Kanäle bestehen aus Sur1
oder 2 und Kir6.1 oder 6.2 Untereinheiten und stellen einen intrazellulären
Energiesensor der Zelle dar. Unsere Hypothese war, dass eine Beeinträchtigung dieser
Kanäle zu einer erhöhten elektrischen Aktivität der mesDA Neurone führt, die diese
unter erhöhten physiologischen Stress setzt, der ultimativ den Tod der Zelle
verursacht. Die Analyse von sowohl Sur1 als auch Kir6.2 Mausmutanten zeigte aber
keine Veränderungen im Bezug auf das mesDA System, also hat ein Verlust von
funktionalen KATP Kanälen keine Auswirkungen auf das Überleben der Neurone.
Nachdem Liss und Kollegen in Kir6.2 Mutanten einen reduzierten Zelltod feststellten,
wenn diese Tiere mit einem Toxin behandelt wurden, änderte ich meine Hypothese
dahingehend, dass der normale Status der KATP Kanäle von Offen und Geschlossen
das Überleben der Zelle beeinflusst, wenn diese unter physiologischem Stress steht. In
dieser Arbeit zeige ich, dass die Blockade von KATP Kanälen einen positiven Effekt
und die Öffnung einen negativen Effekt auf mesDA Neurone hat, wenn diese unter
oxidativem Stress stehen. Des weiteren zeige ich, dass ein Fehlen von KATP
Kanalexpression in En1-/+:En2-/- Mäusen zu der Wiederherstellung des mesDA
Wildtyp-Phänotyps führt. Dies ist ein Hinweis für die Bedeutung der KATP
Kanalfunktion und kann zu neuen Ansätzen in der Entwicklung von Parkinson-
Medikamenten führen.
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1 Introduction
The introduction consists of following topics:
- a short overview to describe the line of reasoning, the engrailed phenotype, the
Fox genes and KATP channels
- important genes and how they influence mesDA development
- the mature mesDA system and its relation to Parkinsons Disease (PD)
- genetic and environmental risk factors of PD
- toxins as PD model systems
- evidence pointing to a role of KATP channels in mesDA neurons
- KATP channel structure and function
- goals of this work
1.1 Overview
The dopaminergic (DA) neurons of the ventral midbrain constitute several distinct
sub-populations which are involved in emotional control, reward behavior and motor
control (Fasano and Brambilla, 2002; Kawagoe et al., 2004; Kitai et al., 1999;
Spanagel and Weiss, 1999). In patients with Parkinsons Disease (PD), cells of one of
these groups, the DA neurons in the substantia nigra, pars compacta (SNpc) gradually
die. The main innervation target of these cells, the striatum, is depleted of dopamine,
leading to resting tremor, bradykinesia, postural instability and rigidity of muscles as
the classical symptoms (Duvoisin, 1992; Fahn, 2003).
Investigation of familial cases of PD led to the discovery of several mutated genes,
implicating a deficiency in protein degradation, impairment of safe-guards against
exitotoxicity and oxidative stress. Additionally, several mutations in mouse and a
number of toxins all lead to a more or less distinct degradation of the nigral DA
neurons and leave other dopaminergic populations unaffected. Whereas some of these
events specifically target mesDA neurons (either because the mutated gene is
expressed solely in these neurons or the toxin is only taken up by them) the cause of
the death in other cases is less clear and points to a specific vulnerability of the nigral
DA neurons to cellular stressors.
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1.1.1 The engrailed phenotype
In engrailed mutant mice, the absence of the homebox transcription factors engrailed
1 and engrailed 2 (En1 and 2) causes a cell-autonomous and gene-dose dependent loss
of mesDA neurons. The two proteins can compensate for each other, so that both
En1-/- and En2-/- mutations alone do not affect the mesDA neurons, aside from cell
density in the case of En1 (Simon et al., 2001). In the En2-/- background, however, a
single deletion of En1 (hereafter referred to as EnHT) causes a progressive loss of
SNpc neurons starting around postnatal day 15 (P15) and peaking at P90 (Sgado et
al., 2006). Mice with a double homozygous deletion of both isoforms lose the
complete set of mesDA neurons between embryonic day 12 (E12) and E14. The cells
do not undergo a change in cell fate (Simon et al., 2001). The progressive loss in the
EnHT mice mirrors the loss of SNpc neurons in PD patients, where those are the most
affected while the neuronal population of the neighbouring ventral tegmental area is
not or only slightly impaired. Recently, our lab performed a differential display
analysis, in which ventral mesencephalic tissue from three sources was used to search
for genes which are specific to mesencephalic neurons and/or under the control of the
engrailed genes (Thuret et al., 2004).
1.1.2 Possible roles of Foxa1 and Foxa2
Among the differentially expressed genes identified, the fork head containing
transcription factor 1, Foxa1 (formerly HNF3α) (Costa et al., 1989; Lai et al., 1990),
was of particular interest, as it is expressed in mesDA neurons from E9 onwards.
However, analysis of the mouse Foxa1 mutant (Kaestner et al., 1999) showed no
change in the level of expression of the gold-marker for dopaminergic neurons, the
rate-limiting enzyme of dopamine synthesis, tyrosine hydroxylase (TH), as well as the
expression of several other genes known to be expressed by mesDA neurons. As it is
well known that members of the Fox/HNF family of genes can compensate for each
other (Lee et al., 2005; Sund et al., 2000; Wan et al., 2005), I focused my research on
two downstream genes of the Fox family, the KATP channel forming proteins Sur1 and
Kir6.2.
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1.1.3 KATP channels in systems of cellular stress
KATP channels in neurons act as control elements by coupling the metabolic state of
the cells to their membrane potential, therefore I thought it possible that misregulation
or impairment of these channels may lead to an increased electrical activity of the
mesDA cells, putting them under heightened physiological stress that then may in turn
cause cell death when other factors are added (Liss et al., 2005). KATP channels are
octaheteromeres of 4 sulfonyl receptor (SUR) sub units and 4 inwardly rectifying
potassium channel elements (KIR6.x). In a given channel, both SUR and KIR6.x sub
units are of the same type and this combination is specific to a certain type of cell. In
mesDA neurons, only Sur1, Sur2 and Kir6.2 isoforms are expressed (Liss et al.,
1999a).
Our analysis of both Sur1 and Kir6.2 mutant mice showed no change in TH+ cell
number, cell density or density of axonal projections, thus a loss of functional KATP
channels has no effect on the survival of mesDA neurons. When Liss and colleagues
found that a decreased cell loss occurs when Kir6.2 mutant mesDA cells suffer a toxin
insult (Liss et al., 2005), I revised my hypothesis: Not a loss of function of KATP
channels is causing mesDA cell loss, but the normal opening may be a contributing
factor.
In order to adress this hypothesis, I investigated the effect of open and closed KATP
channels on the cell survival of mesDA neurons. I used both pharmacological
reagents in vivo and vitro and homozygous recombinant mutant mice deficient of the
channels. Furthermore, I studied the effect of a non-functional KATP-channel on the
EnHT mice, which normally show a progressive mesDA cell loss.
Introduction
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1.2 The Development of Midbrain Dopaminergic Neurons
1.2.1 Early Development
MesDA neurons are some of the first neuronal populations in the mammalian central
nervous system (CNS) which become postmitotic (Altman and Bayer, 1981). The
region in which these cells are generated is laid down after the fore-, mid- and
hindbrain has been specified (Joyner, 1996). Their progenitors receive positional
information from several organizing centers during their development. In mammals,
two of these centers, the anterior visceral endoderm (AVE) and the node, are both
induced by extraembryonic tissue. In mice, this happens around E7-E8.
Figure 1.1: Gene expression domains in the developing midbrain
Overview of genes which are important for the development of mesDA neurons. These genes provide
positional information and change the fate of progenitor cells to enter a mesDA developmental
pathway (Alavian et al., 2007).
For the AVE, signals from the extraembryonic ectoderm induce Nodal expression in
the underlying cells of the epiblast which leads to the development of this centre
(Brennan et al., 2001). The trophoblast induces node formation in the epiblast via the
Introduction
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expression of Arkadia (Episkopou et al., 2001). The AVE then in turn induces head
formation and the first factors sub-dividing the brain start to be expressed, among
them the drosophila orthodenticle homologue 2, Otx2.
1.2.2 Regionalisation of the Brain
1.2.2.1 Otx2 and Gbx2
The expression of Otx2 and the gastrulation brain homeobox gene Gbx2 defines the
position of another of the organizing centres in the brain, the mid/hindbrain boundary
(MHB), also called isthmus or mid/hindbrain organizer (MHO). By repressing each
other as well as defining/limiting the expression of genes along the rostro-caudal axis
of the brain they form two areas bordering on each other. At this border, the MHB is
formed.
Before gastrulation, Otx2 starts to be expressed in the epiblast and anterior visceral
endoderm (Matsuo et al., 1995; Simeone et al., 2002). Later in development, the
expression domain of Otx2 narrows to a region comprising the fore- and midbrain
regions (Broccoli et al., 1999). In the Otx2 mutant mice, the forebrain and midbrain
regions are deleted (Acampora et al., 1995), whereas the expression domain of Otx2
is enlarged caudally in Gbx2 mutant mice (Wassarman et al., 1997) (Millet et al.,
1999). Similarly, Gbx2 expression, initially present in all three germ layers from the
posterior embryo up to the hindbrain, is limited to the anterior hindbrain by E8.5
(Wassarman et al., 1997).
Mice ectopically expressing Gbx2 in the midbrain lose all mesDA neurons normally
generated in that region by a shift of the hindbrain rostrally (Millet et al., 1999). In a
similar experiment, ectopic expression of Otx2 in the rostral hindbrain expands the
area where mesDA neurons are forming (Puelles et al., 2004).
In Otx2/Gbx2 double mutant mice, the expression of MHB genes like the fibroblast
growth factor 8 (Fgf8) is unchanged, although they have been shifted to a more
anterior position, suggesting that the expression of these genes is necessary for proper
placement of the MHB but not for the initiation of expression of genes (Li and Joyner,
2001).
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1.2.2.2 Pax2, Pax5, Pax6
The position of the MHB is further maintained by the paired box genes, Pax2, Pax5
and Pax6. Pax2 is expressed from E7.5 on in the anterior mouse embryo before neural
tube closure. Later, its expression in the CNS is restricted to the neural plate of the
prospective midbrain/hindbrain (Rowitch and McMahon, 1995).
Pax5 is expressed later (E9.5/3-somite stage) and in contrast to Pax2, which is also
expressed in the developing eye, ear and urogenital tract (Bouchard et al., 2000), it is
specific to the developing brain (Rowitch and McMahon, 1995) (Asano and Gruss,
1992). Both Pax2 and Pax5 are expressed in the mes/metencephalon (Mastick et al.,
1997).
In Pax2/5 double mutant mice, the posterior midbrain and the cerebellum are lost
(Figure 1.1). However, one wild type Pax2 allele is necessary and sufficient to rescue
the mouse to a normal patterning of midbrain and cerebellum (although there are still
severe malformations in other parts of the body) (Urbanek et al., 1997).
Pax2 expression is unchanged in Pax5 mutants and vice versa, suggesting that both
genes do not regulate each other (Schwarz et al., 1997). However, Pax2 and Pax5 are
structurally so similar that cloning of the Pax5 gene into the Pax2 locus completely
rescues the embryo from the Pax2 -/- phenotype in respect to cerebellum and
midbrain effects, as well as in the developing eye, ear and urogenital system, where
Pax5 is not expressed (Bouchard et al., 2000).
Pax6, on the other hand, is expressed in the forebrain and hindbrain vesicles (Walther
and Gruss, 1991). The caudal limit of Pax6 expression in the forebrain marks also the
posterior commissure separating fore- from midbrain. In mice lacking Pax6, the pre-
tectum normally developing at the posterior commissure is lost and the boundary
between fore- and midbrain is shifted rostrally (Mastick et al., 1997).
In summary, the Pax genes are expressed at an early point in brain development and
delineate the major brain regions, reinforcing the MHB, which forms a signaling
centre at the rostrocaudal axis and positions the region where mesDA neurons will
form.
Introduction
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Figure 1.2: Schematic representation of a wild type and Pax2/5 double mutant mouse brain.
The posterior midbrain and the cerebellum, the areas where Pax2 and Pax5 are normally expressed, are
severly reduced in the double mutant (Schwarz et al., 1997).
1.2.3 Defining the Ventral Midbrain
The early dorso-ventral axis of the CNS is defined by both a morphological border
and by the secretion of diffusible factors. The sulcus limitans provides a physical
barrier between the ventral floor and basal plates and the dorsal alar and roof plates.
The diffusible factors, for example the bone morphogenic proteins (BMPs) (De
Robertis and Kuroda, 2004; Rhinn et al., 2006) are secreted by the roof plate in a
dorsal to ventral gradient, whereas sonic hedgehog (Shh), a drosophila hedgehog
homologue, is secreted from floor plate and notochord (Ye et al., 1998). Shh and the
fibroblast growth factor 8 (Fgf8) act together to induce mesDA development. While
Shh provides a ventral to dorsal gradient, the Fgf8 is secreted along the rostral-caudal
axis of the developing embryo. Together with Fgf4, they provide responsive cells
with positional information for the induction of dopaminergic and serotonergic cell
fates (Ye et al., 1998). Fgf8 is part of group of genes expressed at or around the MHB
which form a feedback loop of expression. This loop maintains gene expression and
provides a reinforcement of positional identity along the rostro-caudal axis.
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1.2.3.1 Fgf8 and Shh
The narrow expression of Shh at the level of the floor plate of the posterior part of the
neural tube (at the level of spinal cord and hindbrain) widens at the MHB to cover
almost the entire basal plate of the midbrain and caudal forebrain (Echelard et al.,
1993; Ye et al., 1998). Cells bind Shh at Patched receptor complexes and transduce
the signal via Smoothened transmembrane proteins and Gli family transcription
factors (Fuccillo et al., 2006) (Blaess et al., 2006). While early experiments suggested
that Shh is sufficient and necessary for induction of mesDA neurons (Hynes et al.,
1995), more recent work provides evidence that Shh functions more like a survival
and proliferation factor than a true patterning molecule (in respect to midbrain
development), as the gene expression and morphology of the developing midbrain
does not change when Shh is ablated (Britto et al., 2002; Ishibashi and McMahon,
2002). Nevertheless, Shh critically maintains expression of Fgf8 (Blaess et al., 2006)
at the MHB and of Pax6 (Ericson et al., 1997).
When Fgf8 soaked beads were implanted into the diencephalon (prosomere 2) of
chicken embryos, an ectopic En2, Fgf8 and Wnt-1 expression could be detected
(Crossley et al., 1996). Implantation into a more caudal part of the diencephalon
(prosomere 1) or directly into the midbrain led to the same result, but signal spread
across the prosomere boundaries was restricted (Martinez et al., 1999). The 5’
promotor region of Fgf8 has intronic binding sites for both the engrailed and Pbx1
proteins (Gemel et al., 1999). Fgf8 is also able to induce Pax2 and Pax5, Wnt1, and
Gbx2 and to repress Otx2 (Liu and Joyner, 2001b; Liu et al., 1999). Ectopic
expression of either En1/2, Pax2 and 5 and Fgf8 in the diencephalon leads to the
expression of the other genes from that group and pushes the diencephalic cells into a
tectal path of development (Araki and Nakamura, 1999; Funahashi et al., 1999;
Okafuji et al., 1999). This demonstrates the ability of Fgf8 to establish a feedback
loop which strengthens the MHB in the wild type.
Two other members of the fibroblast growth factor family, Fgf17 and Fgf18 are also
expressed at the isthmus and are maintained by Fgf8 (Liu et al., 2003; Maruoka et al.,
1998; Xu et al., 1999). When beads containing Fgf8 where implanted into embryos,
an ectopic expression of both Fgf17 and Fgf18 was observed (Liu et al., 2003). In
mesencephalon/rhombomere-1-specific conditional Fgf8 knock-out mice, expression
of both genes is initiated but lost rapidly (Chi et al., 2003). Mis-expression of
Introduction
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Fgf17/18 in chicken expands the midbrain and leads to the expression of genes similar
to those seen in a similar experiment with Fgf8a (Liu et al., 2003).
1.2.3.2 Wnt1, Wnt3a and Wnt5a
Wnt1 and Wnt5a (and to a lesser extend Wnt3a), homologues of the drosophila
wingless segmentation gene, are expressed in the developing midbrain of the mouse
from around E8.5. Wnt1 is also expressed in the dorsal roof plate. Wnt1 expression is
located anterior of the MHB and in two stripes on both sides of the medial floor plate
within the cephalic flexure (Bally-Cuif et al., 1995). Mice lacking Wnt1 expression
are completely lacking the midbrain, cerebellum and the anterior hindbrain, as well as
the initially present expression of other genes important for mesDA development like
En1, En2 and Fgf8 (McMahon and Bradley, 1990) (McMahon et al., 1992). Wnt1
regulates the expression of homeobox transcription factor engrailed 1 (En1) (Bally-
Cuif et al., 1995). Expressing En1 under control of the Wnt1 enhancer in Wnt1-/-
mice leads to an almost complete rescue of the Wnt1 phenotype (Danielian and
McMahon, 1996). In vitro, Wnt1 predominantly increases the proliferation of Nurr1
positive precursors and Wnt-5a increases the fraction of these Nurr1 positive cells
expressing Pitx-3 and c-Ret. This suggests that both Wnt1 and Wnt5a, which is
specific to the ventral midbrain, are necessary for proper proliferation and
differentiation of mesDA neuron precursors (Castelo-Branco et al., 2003). A newer
report by the same group suggests that Wnt function is mediated through secretion by
local glia cells which maintain their regional identity by expressing Pax2, En1 and
Otx2 (Castelo-Branco et al., 2006) and, on the molecular level, by activating the
canonical (Wnt3a) and non-canonical (Wnt5a) pathways of Wnt-signaling (Schulte et
al., 2005).
1.2.3.3 Engrailed 1 and engrailed 2 (early function)
The homeobox transcription factors engrailed 1 and 2 are expressed around the
forming MHB from the 1-somite stage (En1) and 3-5-somite stage (En2) onwards
(Joyner et al., 1985) (Davis and Joyner, 1988; Joyner and Martin, 1987). Despite a
low sequence homology of 30% outside the homeobox, En2 cloned into the En1 locus
is able to compensate for En1 and rescue the otherwise lethal En1-/- mouse mutant
(Hanks et al., 1995). In En1/2 double knock-out mice, large portions of mid- and
hindbrain are deleted, as well as the cerebellum. These reductions are 
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noticeable in En1-/- mice which also have cerebellar defects (Wurst et al., 1994) but
not in En2-/- mice, where only a slightly erroneous cerebellar foliation can be
observed (Joyner et al., 1991; Millen et al., 1994). The large deletion in En1/2
mutants is similar to the phenotype of the Wnt1 mutation (McMahon and Bradley,
1990; McMahon et al., 1992; Thomas and Capecchi, 1990). While the early induction
of Fgf8 at the isthmus is independent of engrailed, the later maintenance is under the
regulatory control of En1 and 2 (Liu and Joyner, 2001a). Additional data comes from
experiments done in chicken. Ectopic expression of high levels of En1 via a retrovirus
leads to expression of Fgf8 in ectopic positions in the mesen- and diencephalons
(Shamim et al., 1999). Injection of En2 into 1-2 cell stage embryos of Oryzas or
Xenopus also lead to expression of Fgf8 as well as Pax2, Wnt1 and the gene itself
(Ristoratore et al., 1999).
Figure 1.3: Establishment and maintenance of the MHB
in the mouse.
The mutual repression of Gbx2 and Otx2 at 7-8.5 dpc
establishes the MHB, Fgf8 expression maintains it and
is part of a feedback loop of Fgf8, En1, En2 and Wnt1
from 8.5 dpc onwards (Acampora et al., 2001).
1.2.3.4 Tgfβ
Another gene of interest, the transforming growth factor beta (Tgfβ), is also expressed
in the midbrain floor plate from E3 onwards in chicken (Unsicker et al., 1996). It is
not sufficient for the early induction of the mesDA neurons. Neutralizing either Shh
in the presence of Tgfβ or Tgfβ in the presence of Shh impairs the development of
mesDA neurons in E12 rat embryonic ventral midbrain cells but does not affect the
noradrenergic neurons of the locus coeruleus or the dopaminergic neurons of the
diencephalon (Farkas et al., 2003). Incubation of chicken embryos with a Tgfβ
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antibody before the mesDA neurons have been generated leads to a 60% cell loss five
days later. There is always a loss of mesDA neurons, no matter when the antibody is
added to the chicken embryos. This also happens, even if the cells have finished
maturation, suggesting that Tgfβ not only acts as an inducing factor in generation of
these neurons but also as an survival factor later in development and adulthood
(Roussa and Krieglstein, 2004).
1.2.4 Differentiation of the mesDA precursors
After the establishment of the MHB and the induction of mesDA development, the
precursor cells start to express a number of genes specific for dopaminergic neurons
(like the rate-limiting enzyme of dopamine synthesis, tyrosine hydroxylase (TH)).
Some of these genes are furthermore only expressed in the DA cells of the ventral
midbrain and not found in other dopaminergic populations in the brain, making them
targets for investigation in order to understand the distinct vulnerability of the
dopaminergic neurons of the nigra.
1.2.4.1 Lmx1a and Lmx1b
Among the genes necessary for proper mesDA differentiation are two structurally
related proteins, Lmx1a and Lmx1b. They encode LIM homeodomain-containing
transcription factors. Despite having roles in early development, both are still
expressed after E9.5. Lmx1a is an early activator of differentiation, e.g. maintaining
expression of Msx1, both of which then activate Ngn2 expression (Kruger et al., 2002;
Millonig et al., 2000). Ngn2 is necessary for an early shift of progenitor cells from
glial to pro-neural fate (Bertrand et al., 2002), while Msx1 expression prevents
mesDA progenitor cells from entering alternative cell fates by repressing other genes
like Nkx6.1, which is required for the generation of motor neurons in the spinal cord
(Vallstedt et al., 2001). Lmx1a is also necessary and sufficient to induce ectopic
mesDA neurons in chicken embryos; these neurons express Nurr1, En1, Pitx3, Lmx1b
and DAT like wild-type mesDA neurons. When Lmx1a expression is knocked down
with RNAi, a reduction of mesDA cell number can be seen (Andersson et al., 2006).
At E7.5, Lmx1b is widely expressed in the caudal forebrain, midbrain, and hindbrain
but eventually its expression becomes restricted to the SNpc and VTA (Burbach et al.,
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2003). Within the cephalic flexure, mesDA neurons of Lmx1b-/- mutants show a lack
of Pitx3 expression but not of TH or Nurr1 (Burbach et al., 2003). At E12.5, neurons
are present which express Pitx3 but not TH or vice versa, suggesting that these
neurons have not matured properly. Lmx1b is also required for the induction of Wnt1
expression in the chicken mid/hindbrain boundary region as well as being maintained
by Fgf8 (Adams et al., 2000). It is possible that the effect of Lmx1b on Pitx3 is in fact
via its control over Wnt1 expression (Riddle and Pollock, 2003; Smidt et al., 2000).
1.2.4.2 Engrailed 1 and engrailed 2 (late function)
The two homeobox transcription factors En1 and En2 are not only important for the
early establishment and maintenance of the MHB, they start to be expressed on both
sides of the isthmus around E11.5 and E14 in mice and are expressed in mesDA
neurons during adulthood (Joyner et al., 1985) (Davis and Joyner, 1988; Joyner and
Martin, 1987).
Via cell-mixing and RNAi experiments as well as through the generation of chimeric
mice, our lab was able to show that engrailed is necessary for the survival of mesDA
neurons in a cell-autonomous manner (Alberi et al., 2004) and that the neurons are
not lost because the surrounding cells lack this gene. The engrailed-deficient mesDA
neurons start to disappear at exactly the time when engrailed starts to be expressed.
There is also a gene-dose dependency of engrailed by the mesDA neurons, as the loss
of these cells becomes more pronounced, the more alleles of the two engrailed genes
are deleted. For instance, mice with an En1-/+:En2-/- mutation initially have a normal
number and distribution of mesDA neurons, however, as time progresses, these cells
are lost, starting at P15 and peaking at 3 months of age with an 80% loss (Sgado et
al., 2006). In the full double mutant, the cells are completly lost. While this loss can
be observed as early as E9, the mesDA neurons are first generated and even start to
express their transmitter phenotype, but die between E12 and E14 (Simon et al.,
2001).
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Figure 1.4: The EnHT
(En1-/+:En2-/-) midbrain
phenotype.
(picture divided in two
parts)
Dopaminergic neurons of
the substantia nigra are
p r o g r e s s i v e l y  l o s t
(compare wild type A, C,
E with A’, C’, E’: cell
count in J on the next
page). The dopaminergic
n e u r o n s  i n  t h e
neighbouring VTA and
retrorubal field are not
a f fec ted ,  nor  a re
noradrenergic neurons in
the locus coruleus and
locus subcoruleus (NSC).
The EnHT (En1-/+:En2-/-
) midbrain phenotype.
Dopaminergic neurons of
the substantia nigra are
p r o g r e s s i v e l y  l o s t
(compare wild type A, C,
E with A’, C’, E’: cell
count in J) .  The
dopaminergic neurons in
the neighbouring VTA
and retrorubal field are
not affected, nor are
noradrenergic neurons in
the locus coruleus and
locus subcoruleus (NSC).
Adapted from (Sgado et
al., 2006).
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1.2.4.3 Pitx3
The paired-like homeodomain transcription factor 3 (Pitx3) is, with the exception of
the eye, only expressed in the mesDA neurons of the ventral midbrain. The expression
starts between E11.5 and E12.5 (Smidt et al., 1997). In aphakia mice, which are
Pitx3-/-, the neurons of the SNpc but not of the VTA are lost. It has been speculated
that this might be due to differences in the molecular setup between the neuronal
populations of the SNpc and VTA areas (Nunes et al., 2003). The mesDA loss lowers
the level of dopamine in the striatum by ca. –90% (Smidt et al., 2004), the mice,
however, fail to develop strong motor deficits. A lower motor activity can be
observed which is treatable with L-DOPA, the same medication Parkinson patients
receive. On the cellular level, the mesDA neurons in aphakia mice fail to migrate
early in development. However, it is likely that Pitx3 has other functions in the
terminal differentiation and/or early maintenance of these cells, as they have already
finished proliferation by the time Pitx3 starts to be expressed (Smidt et al., 2004).
Pitx3, as well as Nurr1, controls the expression of TH in nigral DA neurons by
activating the promotor through a high affinity binding site (Lebel et al., 2001;
Maxwell and Li, 2005). In a number of in vitro experiments in which cells were
artificially differentiated, Pitx3 was shown to induce the expression of mesDA
specific genes (Sasai, 2002) (Zigova et al., 2000).
1.2.4.4 Nurr-1
Nurr-1 (also known as Nr4a2, NOT, RNR-1 and HZF3) is a nuclear receptor
belonging to a conserved superfamily of ligand-activated transcription factors
(Aranda and Pascual, 2001; Giguere, 1999). Its called an orphan receptor because its
ligand binding site is blocked by hydrophobic amino acid side chains (Volakakis et
al., 2006). It may, however, bind to RXR nuclear receptors and these heterodimers
may in turn be activated by cognate ligands like docosaheaenoic acid (Wang et al.,
2003).
Nurr1 starts to be expressed in the ventral midbrain, as well as in other DA nuclei of
fore- and hindbrain, at around E10.5 in mice, the time when mesDA neurons start to
express TH and leave the cell cycle (Zetterstrom et al., 1996). In Nurr1 mutant mice,
the cells are generated and can be detected by the expression of mesDA specific genes
like Pitx3 and engrailed but they are lost soon after (Perlmann and Wallen-
Mackenzie, 2004). The cells fail to express vesicle monoamine transporter 2
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(VMAT2), dopamine transporter (DAT) and TH (Castillo et al., 1998) (Smits et al.,
2003). Not surprisingly, Nurr1 is able to bind directly to the TH promotor (Kim et al.,
2003) and a similar binding sequence was found in the DAT promotor (Sacchetti et
al., 2001; Sakurada et al., 1999).
TH expression is not impaired in the DA nuclei of the olfactory bulb, diencephalons,
as well as in the hindbrain and brain stem, where Nurr1 is not expressed. There is
conflicting evidence if the normal target innervation of mesDA neurons in Nurr1
mutants is present or not ((Wallen et al., 1999) and (Zetterström et al., 1997) vs.
(Witta et al., 2000)). In Nurr1 mutant mice, the tyrosine kinase Ret, which is an
important co-receptor for tropic factors like GDNF, is not expressed either (Baloh et
al., 1997; Robertson and Mason, 1997) (Wallen et al., 2001). GDNF is one of the
pivotal tropic factors required for the postnatal survival of mesDA neurons, as well as
being protective against neurotoxin induced cell death (Burke et al., 1998; Clarkson et
al., 1995; Tomac et al., 1995).
Given its relatively late expression in mesDA neurons, Nurr1 has been considered a
purely post-mitotic survival factor which is also important for terminal differentiation.
In neuronal stem cell culture, Nurr1 together with Pitx can induce terminal maturation
of ES cell cultures into midbrain dopaminergic phenotype (Martinat et al., 2006).
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Figure 1.5: Timeline of gene expression and their function in mesDA neurons.
This picture shows the chronological order of genes important for mesDA neuron development.
Dashed lines represent expression in the region and not necessarily in the mesDA neurons (Alavian et
al., 2007).
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1.3 The mature mesDA system
The mesDA neurons of the adult human are divided into three subpopulations which
form distinct pathways and innervate different target areas in the brain. The neurons
of the retrorubral field (RRF, also called A8), the ventral tegmental area (VTA, also
called A10) which forms the meso-limbic and meso-cortical pathways, innervating
areas in the neocortex and the ventral striatum (Bayer et al., 1995; German et al.,
1989). Functionally, these neurons are linked to emotion and reward and involved in
schizophrenia and drug addiction (Tzschentke and Schmidt, 2000). The last
subpopulation, the neurons of the substantia nigra pars compacta (SNpc, also called
A9), targets the dorsal striatum. Proper function of this population is necessary for the
induction and coordination of movement (Kish et al., 1988).
Figure 1.6: The dopaminergic nuclei of the murine brain and the innervation targets of SNpc and VTA.
MesDA neurons coming from the SNpc innervate the dorsal striatum/globus pallidus, VTA neurons
innervate predominantly areas in the prefrontal cortex and olfactory tubercle. (a and b adapted from
(Smidt and Burbach, 2007), lower picture (Prakash and Wurst, 2006))
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1.4 Parkinson’s Disease (PD)
In 1817, the english doctor James Parkinson described in his publication “An Essay
on the Shaking Palsy” (reprinted in (Parkinson, 2002)) a disorder causing
“Involuntary tremulous motion, with lessened muscular power, in parts not in action
and even when supported; with a propensity to bend the trunk forwards, and to pass
from a walking to a running pace; the senses and intellects being uninjured.” This
disorder, now known as Parkinson’s Disease was subsequently linked to a loss of
nigral DA neurons (Tretiakoff, 1919). In order to be diagnosed with Parkinsonism,
patients have to show at least two of the six symptoms of resting tremor, flexed
posture, the on-and-off inability to move the feet, postural instability, rigidity and
bradykinesia. One of the two symptoms has to be either tremor or bradykinesia.
Furthermore, to be diagnosed with PD, theses symptoms have to have an asymmetric
onset, include resting tremor and show a good response to levodopa (Fahn, 2003;
Gibb and Lees, 1988; Hughes et al., 1992). The motor impairments are linked to a 70-
80% loss of the mesDA neurons in the substantia nigra (Bernheimer et al., 1973). PD
affects roughly 1-3% of the human population over the age of 60-65 (de Rijk et al.,
2000), while familiar forms occur rarely but with an onset as early as 30 years age.
The prevalence of PD is similar among different ethnic groups, but different between
the same ethnicities in different locations (Schoenberg et al., 1988).
The loss of the SNpc neurons is distinct, no other neuronal populations are similarly
affected, though degeneration can be detected in other areas (locus coeruleus, raphe
nuclei, nucleus basalis of Meynert, cingulate and entorhinal cortex, olfactory bulb and
autonomic nervous system) (Schulz and Falkenburger, 2004). Cellular inclusions
containing predominantly α-synuclein and ubiquitin (Spillantini et al., 1997), the so-
called Lewy-bodies, are present throughout the brain (Ohama and Ikuta, 1976) (Braak
and Braak, 2000), altough their possible role in the progress of the disease is still
unclear (Gibb and Lees, 1988) (Lang and Lozano, 1998) (Fahn, 2003). The DA
neurons are lost progressively up to the point where the remaining neurons can not
longer compensate for the falling level of dopamine in the striatum and the motor
symptoms start to appear (German et al., 1989). The effect on other parts of the brain
can be seen by the development of secondary symptoms, e.g. 25 to 40% of PD
patients develop dementia as well as depression and panic attacks. The range of
secondary symptoms differs from patient to patient and may include fatigue, sleep
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disorders, problems with digestion (e.g. constipation, megacolon) and sensory
symptoms including pain, numbness, tingling and burning sensations in up to 40% of
patients (Fahn, 2003).
Despite biochemical changes and reduced number of axon terminals, the mesDA
neurons of aged healthy humans and other primates (De Keyser et al., 1990) (Kubis et
al., 2000; McCormack et al., 2004; Rinne et al., 1990) are not reduced in number. PD
is therefore not the result of the naturally occuring aging process, although age is a
risk factor.
Figure 1.7: Coronal sections of human brains showing SNpc of a healthy and a PD human subject
The graphic depicts normal and affected striatal innervation. Note the reduced color in the nigra of the
PD brain. (picture adapted from (Dauer and Przedborski, 2003))
1.4.1 Genetic and environmental risk factors of PD
No singular event causes Parkinsons Disease, nor is there a clear picture which of a
various number of factors has to be present for an individual to develop the so-called
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sporadic PD. However, the disease is most likely caused by a convergence of genetic
pre-disposition and environmental factors affecting a person throughout his or her
life. Over the years, screenings for risk factors in the populace of various countries
were undertaken.
1-3% of all PD cases develop the symptoms at an earlier age than the majority of
patients. Often under 50 years of age, in some cases as young as 20, these PD patients
have frequently a familiar history of PD at similar ages. The identification of carrier
families and genetic screening lead to the identification of, up to date, thirteen
genomic loci, dubbed PARK genes. In seven of these loci the mutated gene could be
identified. This offered an insight into the molecular workings of the disease. The
known mutations with identified underlying protein can be grouped according to their
penetrance, the autosomal recessive mutations of Parkin, PINK1 and DJ1 and the
autosomal dominant mutations of alpha synuclein, LRRK2 and UCH-L1. These will
be discussed on the next pages.
1.4.1.1 The recessive mutations (Parkin, DJ-1 and Pink1)
The first identified gene was Parkin, a member of the RING family of proteins. It has
a ubiquitin-ligase domain at the amino terminus and there is evidence that it acts in a
complex with a range of proteins to tag specific proteins for degradation (Staropoli et
al., 2003). There is no direct evidence how a mutation in these genes might cause PD;
the most common hypothesis speculate that dysfunction of Parkin causes abnormal
protein aggregation, leading either to a not clearly defined mass of proteins or to a
distinct aggregation of PD-relevant proteins e.g. α-synuclein, one of the proteins
found in Lewy bodies. A third hypothesis puts parkin in a cell-survival context,
arguing that over-expression of parkin is protective in several cell-apoptosis models,
maybe indirect via its various substrates, some of which act in cell survival. However,
mice deficient for parkin show little or no alteration in cell numbers (aside from the
locus coruleus in one case) and evidence for changes is dependent on the genetic
background of the mice. (Goldberg et al., 2003; Itier et al., 2003; Perez and Palmiter,
2005).
DJ-1 belongs to the Thi domain family and is associated with chaperone, protease and
other functions. Its chaperone function is activated by oxidative stress and supressed
in a reducing environment. When oxidized, this chaperone function appears to have a
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wide range of targets, including binding to and preventing the fibrilization of α-
synuclein (Shendelman et al., 2004; Zhou et al., 2006).
DJ-1 deficiency makes dopaminergic neurons sensitive to oxidative stress
(Shendelman et al., 2004), whereas over-expression is protective against oxidative
toxic insults (Canet-Aviles et al., 2004; Martinat et al., 2006; Taira et al., 2004).
Pink1 (PTEN-induced kinase 1, PARK6) is a protein with a serine/threonine kinase
domain and a mitchondrial targeting sequence. It normally accumulates in the
intermembrane space of mitochondria. All known mutations of this gene in humans
lead to a reduced or total loss of function of the protein, either by a reduction of
transported protein to the intermembrane space or by an impairment of the kinase
activity (Palacino et al., 2004; Periquet et al., 2005; Valente et al., 2004).
The small amount of data on gene function in humans is somewhat offset by research
in drosophila. There, inactivation of a Parkin orthologue leads to mitochondrial
dysfunction in flight muscle and sperm, causing progressively sterility, an inability to
fly and a reduced survival rate. However, since human Parkin cannot compensate for
a loss of the orthologue in drosophila, it is still unclear if the proteins are
interchangeable.
As with Parkin, the mouse mutant of DJ-1 shows little alteration on the cellular level
while there is evidence for increased sensitivity to oxidative stress in drosophila
(Menzies et al., 2005; Meulener et al., 2005).
The Pink1 mutation effectively mirrors the Parkin phenotype as the flight muscle
function is impaired, as well as the sperm motility. Furthermore, Parkin over
expression in drosophila null for Pink1 largely rescues the animals, but not vice versa
(Clark et al., 2006; Park et al., 2006). The effect is specific as Parkin over expression
is unable to protect against other, e.g. toxin insults, strongly suggesting that, at least in
drosophila, Parkin is acting downstream of Pink1. Human Parkin protein has the same
protective effect, strengthening the argument that the mechanism is conserved (Clark
et al., 2006; Park et al., 2006). Based on this data, a mechanism by which the three
genes may interact has been proposed (as shown in Figure 1.8).
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Figure 1.8: Unknown substrate proteins (X) are caused to accumulate in a toxic state (Tox-X) by
oxidative stress.
This is thought to activate the JNK/Bax apoptotic pathway which ultimately leads to cell death. DJ-1
may inhibit the formation of Tox-X upstream of Pink1 and Parkin, which are part of a degradation
pathway (Abeliovich and Flint Beal, 2006).
1.4.1.2 The dominant mutations (α-synuclein, LRRK2, UCH-L1)
α-Synuclein is the most promiment member of the PARK genes as its mutations are
not only linked to PD, but also the protein itself can be isolated from the fibrillary
mass of Lewy bodies (same as the more recently identified UCH-L1, see below),
providing a link between familiar and idiopathic PD (Polymeropoulos et al., 1997;
Spillantini et al., 1997). The neuronal function of α -synuclein is connected to
neurotransmitter release; in its absence vesicle trafficking is altered in knock-out mice
and in vitro (Abeliovich et al., 2000; Cabin et al., 2002; Fortin et al., 2005). It has
also been implicated in defective protein degradation (Tanaka et al., 2001) altered
macroautophagy (Stefanis et al., 2001) and defective chaperone-mediated autophagy
(Cuervo et al., 2004). Over expression of a-synuclein is cytotoxic, both in naturally
occurring human cases as well as in various animal models (Miller et al., 2004;
Singleton et al., 2003).
The 286kDa ROCO family kinase LRRK2 was first described by (Funayama et al.,
2002) in a Japanese family. The protein has low expression levels in the whole brain,
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slightly higher in striatum and parts of the cortex, but is not expressed in the mesDA
neurons (Galter et al., 2006)), putamen and lung (Zimprich et al., 2004). To date, 19
mutations of the gene are known (Taylor et al., 2006). The mutations G2019S and
R1441G are the most well-studied. In Ashkenazi Jews and North African Arabs, the
mutations can be found in over 10% of all PD cases (Lesage et al., 2006); (Ozelius et
al., 2006): outside these groups it is far less common (0.5-1.5%) (Gilks et al., 2005;
Nichols et al., 2005). The mutations are incomplety penetrant (not following a clear
mendelian inheritance pattern) and enhance the chance to develop the disease (Mata
et al., 2005) (Gilks et al., 2005) (Lesage et al., 2006) (Ross et al., 2006). The G2019S
mutation appears to alter the ‘activation loop’ of the kinase domain, based on
structural homology to other protein kinases. The resulting increased kinase-activity
could be the cause of neurodegeneration (Greggio et al., 2006; West et al., 2007).
The expression of UCH-L1 (Ubiquitin carboxy-terminal hydroxylase L1) is neuron-
specific and widespread throughout the brain. Its function is to recycle chains of
ubiquitin to monomers by hydroxylation (Larsen et al., 1998; Solano et al., 2000). It
is also known to have ligase function and one known substrate of UCH-L1 is α-
synuclein. It has been speculated that an alteration preventing the proper function of
this protein may lead to α-synuclein clogging of a cell, disrupting its function and
causing cell death (Liu et al., 2002).
1.4.2 Environmental risc factors
Next to genetic factors, environmental factors have been a major focus of study. The
fact that different populations of the same ethnic group have unequal chances to
develop PD, depending on where they live, points to an influence of environmental
agents. A range of factors has been investigated over the years, for instance exposure
to pesticides (Brown et al., 2006), wellwater drinking, the impact of living in a rural
environment (Seidler et al., 1996), the influence of smoking and coffee drinking and
many more. However, the influence of these factors is not clear yet., as studies
performed on e.g. caucasian and asian populations often show different results
(Schoenberg et al., 1988) (de Lau and Breteler, 2006). However, there is a number of
substances causing a more or less specific SNpc DA cell loss, which has been used in
PD research as a means to induce rapid mesDA degeneration and which where in
some cases identified as humans were exposed and developed PD-like symptoms.
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1.5 Major Toxic Insult systems of PD research
1.5.1 MPTP
1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine is a potent heroin-like by-product of a
meperidine analogue. The appearance of PD-like symptoms in a number of drug-
addicts who injected MPTP contaminated heroin in the early 1980s (Langston et al.,
1983) led to its discovery. It is very lipophilic and easily crosses the blood-brain
barrier. Non-dopaminergic cells take it up and convert it via monoamine oxidase B
(MAO-B) to MPP+. Released into the extra-cellular space, it is actively taken up by
mesDA neurons with dopamine transporter (DAT) (Javitch et al., 1985; Mayer et al.,
1986). In the cells, MPP+ binds to complex I at the same residue that another mesDA
toxin, rotenone, binds and inhibits the respiratory chain (Nicklas et al., 1985). This
leads to a drop in ATP levels in the cell which in turn causes an intracellular calcium
overload (Chan et al., 1991; Fabre et al., 1999). The increased calcium level activates
degrading phosphatases and proteases which disrupt cell function and lead to
apoptosis. High MPP+ concentrations may also promote excito-toxicity via a
glutamate release, leading to a massive influx of calcium by the activation of NMDA
receptors and production of reactive oxygen species (ROS) (Hasegawa et al., 1990).
In mice over-expressing Cu/Zn and Mn superoxide dismutases, two enzymes
deactivating free radicals, the toxicity of MPTP is decreased (Przedborski et al.,
1992).
Furthermore, oxidative damage also depletes intra-cellular ATP levels by activating
poly-ADP-ribose polymerase. In mice lacking that enzyme, the toxicity of MPTP is
significantly reduced (Mandir et al., 1999).
MPTP in primates is able to induce most of the PD symptoms, like tremor, rigidity,
slowness of movement postural instability and even freezing. The group of drug
abusers who suffered from these symptoms reacted positive to treatment with either
L-DOPA or dopamine agonists. Like PD, MPTP causes a greater loss of mesDA
neurons in the SNpc than the VTA (shown for primates (Sirinathsinghji et al., 1992;
Varastet et al., 1994) and mice (Muthane et al., 1994; Seniuk et al., 1990). Unlike PD,
however, there is neither any degeneration in the neurons of the locus coruleus nor
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convincing evidence of Lewy bodies in MPTP-treated primates (Forno et al., 1993).
Additionally, there are signs of reactive microglia and inflammation years after MPTP
insult in human as well as in other primates (Langston et al., 1999; McGeer et al.,
2003).
Figure 1.9: Overview of MPTP action.
(A) MPTP passes the blood-brain barrier and is taken up and converted to MPP+ by non-neuronal cells
via MAO-B. MPP+ is then released into the extra-cellular space and specifically taken up via DAT by
mesDA neurons. (B) Inside the cell MPP+ binds to complex I of the respiratory chain and inhibits ATP
production (Dauer and Przedborski, 2003).
1.5.2 Rotenone
Rotenone is a naturally occurring compound found in the root of many plant species
and has been used as an insecticide and fish toxin. Like MPTP, is a well-studied
inhibitor of complex I of the respiratory chain. Since its very hydrophobic, it passes
the blood-brain barrier with ease and leads to a systemic inhibition of complex I,
unlike MPP+ which specifically taken up only by mesDA neurons (Talpade et al.,
2000). Nevertheless, systemic application in rats led to a distinct neurodegeneration of
mesDA neurons, postural abnormalities and slowness of movement. They also have,
as the only toxin model system, cytoplasmic inclusions reminiscent of Lewy-bodies,
which are immuno-positive for alpha-synuclein and ubiquitine, two proteins
commonly found in Lewy-bodies. The effect of rotenone on rodents, however, is not
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easily reproducible and might vary both within strains as well as between strains
(Betarbet et al., 2000).
1.5.3 6OHDA
6-Hydroxydopamine (6OHDA) was the earliest used compound to induce a
Parkinson-like phenotype in rodents. It cannot pass the blood-brain barrier and is
therefore usually injected unilaterally directly into the brain to produce a more (if the
location of injection is the SNpc) or less (if it is injected into the Striatum) rapid loss
of mesDA neurons. The toxic effect of 6OHDA is thought to involve the generation
of free radicals and oxidative stress (Werner et al., 1994). 6OHDA has the
disadvantage that it does not lead to Lewy bodies and that damage to other neurons is
possible (Beal, 2001). Nevertheless the unilateral loss of mesDA neurons can be used
for testing gene therapies and cell transplantation systems (Bjorklund et al., 2002).
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1.6 Oxidative Stress and KATP channels
Taking both the genetic and toxin based data into account, it appears that both
impairment of protein degradation processes and oxidative stress is involved in
mesDA degenration during PD. In a search for possible downstream targets in the
event of oxidative stress, Liss and Roeper investigated mesDA KATP channels and
their function during a mitochondrial complex I inhibition via MPTP or rotenone. My
own research led to a possible function of the engrailed genes upstream of KATP
channel regulation via the Fox family of genes.
1.6.1 KATP channels
1.6.1.1 KATP channel function
ATP-sensitive potassium channels are non-voltage dependent, selective channels
expressed widely in multiple organs of the mammalian body, including pancreatic
islet cells, heart, skeletal muscle, vascular smooth muscle and brain (Ashcroft, 1988).
They couple cellular metabolism to electrical activity by opening when the
intracellular ATP/ADP ratio decreases and by closing as the ratio increases. Closure
of KATP channels leads to Ca2+ influx. In beta-islet cells, this mechanism leads to the
secretion of insulin whenever the glucose level in the blood (and therefore the
intracellular ATP/ADP ratio) is high.
Figure 1.10: Glucose-
stimulated insulin
secretion.
Glucose is transported
into ß-cells via the GLUT
transpor te r .  Ris ing
intracellular ATP closes
the KATP channels, which
depolarizes the cell
membrane. This opens
voltage-dependent
calcium channels, leads
to an influx of calcium;
the high intracellular
calcium concentration in
the ß-cell triggers insulin
secretion (Miki and
Seino, 2005).
In contrast, events causing the ratio to drop, like ischemia, lead to a K+ efflux and
hyperpolarization of the cell membrane, therefore to a shortening of action potentials
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and conservation of energy, which is thought to protect the cell for a time against
cytotoxic processes (Miki and Seino, 2005).
1.6.1.2 KATP channel structure
KATP channels are formed by the joining of eight subunits, four ca. 40kDa Kir6.x pore-
forming proteins (either Kir6.1 or 6.2), belonging to the inward rectifier K+ channel
family and four ca. 160kDa sulfonylurea receptor proteins (Sur1 and 2), which are
part of the ATP binding cassette (ABC) transporter family. Sur2 exists in two region-
specific isoforms, called Sur2A and B (Inagaki et al., 1996). In each channel, only
one type of Kir6 and one type of Sur is present. The combinations of Kir6.x and Sur
subunits specify their distinct pharmacological and electrophysiological properties. In
mesDA neurons, Sur1 and Kir6.2 isoforms are expressed almost exclusively (Liss et
al., 1999a).
1.6.1.3 Involvement of KATP channel function in mesDA neuron activity
Using patch clamping on both wild type and Kir6.2 mutant mice, Liss et al. identified
Kir6.2 as the sole pore forming part of DA neurons of the SNpc and VTA. RT-PCR
showed Sur1 expressing neurons in similar frequencies in both populations as well as
Sur2 in under 5% of all cases. Expression levels for Sur1 were twofold higher in the
SNpc. Treatment with either 10µM MPTP or 100nM rotenone and subsequent patch
clamping revealed that neurons of the SNpc but not VTA cease spontaneous action
potential firing.
Kir6.2 mutant mice treated chronically with MPTP were resistant to the usually
occurring SNpc cell loss, while the low cell death occurring in the VTA was similar
compared to wild type levels. Furthermore, in a drastic genetic model of mesDA
degeneration, the weaver mouse, inactivation of Kir6.2 by crossing both mutant
strains led to slight reduction of postnatal cell death in the SNpc. Taken together,
activation of plasma membrane KATP channels in the mesDA neurons of the SNpc
leads to cessation of electrical activity, whereas inactivation enables the spontaneous
firing of the neurons again and rescues the cells in both an acute chemical and genetic
model of mesDA cell loss (Liss et al., 2005).
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1.6.1.4 Genetic control of KATP channel expression in the midbrain
A second line of evidence putting KATP channels in a mesDA cell survival context
came from our own research. As stated earlier, in En1-/+:En2-/- mice, the loss of wild
type gene expression leads to a cell-autonomous and gene-dose dependent
degradation of the mesDA neurons (Alberi et al., 2004). In the En2-/- background, a
single deletion of En1 (EnHT) causes a progressive loss of SNpc neurons starting at
around postnatal (P) day 15 and peaking at around 90 days of age (Sgado et al.,
2006).
Our lab recently performed a differential display experiment, in which ventral
mesencephalic tissue from three sources was used to search for genes which are
specific to mesencephalic neurons and/or under the control of the engrailed genes (for
a detailed scheme, see Figure on next page) (Thuret et al., 2004).
1.6.1.5 Foxa1 expression is controlled by engrailed in the midbrain
Among the genes identified in the differential display, the forkhead containing
transcription factor 1, Foxa1 (formerly HNF3a) (Lai et al., 1990), was of particular
interest. It is expressed in mesDA neurons from E9 onwards. However, analysis of the
mouse Foxa1 mutant showed no change in the level of expression of TH, as well as
the expression of several other genes known to be expressed by mesDA neurons.
However, this investigation was limited to young mice, as the full mutant dies
between P2 and P12 (Kaestner et al., 1999). In one of my projects, I tried to generate
a conditional knock-out of Foxa1. However, I was not able to complete this and
focused on the work presented here.
1.6.1.6 Foxa2
As it is well known that members of the Fox/HNF family of genes can compensate for
each other (Lee et al., 2005; Sund et al., 2000; Wan et al., 2005), we focused our
research on the close homologue Foxa2 (formerly HNF3b) (Lai et al., 1991), which is
also expressed by mesDA neurons (Besnard et al., 2004). Interestingly, both Foxa1
and Foxa2 regulate the expression of several mesDA genes during development, for
instance Nurr1, En1 and TH (Ferri et al., 2007). Furthermore, Foxa2 is known to
regulate the expression of the KATP channel forming subunits Sur1 and Kir6.2 in beta-
islet cells (Sund et al., 2001).
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Figure 1.11: Overview of the differential display.
Ventral midbrains of E12 En1/2 mutant mice, wild type, E14 wild type and adult olfactory bulb were
dissected. The mRNA was isolated and used in a RT PCR with random primers to generate DNA
fragments. These were separated on a sequencing gel and the patterns of the lines were compared.
Fragments appearing differentially were excised from the gel and sequenced (Thuret et al., 2004).
However, analysis of both Sur1 and Kir6.2 mouse mutants showed no change in TH+
cell number, cell density or density of axonal projections, thus a loss of functional
KATP channels has no effect on the survival of mesDA neurons. Therefore, I revised
my hypothesis, that not a lack or impairment of KATP channels is causing cell death,
but a functional KATP channel, which opens under physiological stress and leads to
cell death.
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1.7 Goals of this work
In this work, I investigated the effect of a forced open or closed state of the KATP
channel in mesDA neurons. I show that pharmaceutical KATP channel activation
mediates enhanced cell death of TH+ neurons in primary cultures of E12 ventral
midbrain under toxic conditions. I show that, in the reversal of these experiments,
blocking the channel leads to an enhanced survival rate of DA cells compared to
control conditions. Furthermore, I demonstrate that the slow progressive cell loss
occurring in EnHT mice is rescued by crossing the strain with Sur1-/- mice. These
findings point to the KATP channels of the mesDA system as potential targets for
pharmaceutical treatment in Parkinson’s Disease.
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2 Materials and Methods
2.1 Generation of mutant mouse strains and genotyping
The En1/tau-lacZ mice were generated by a knock in strategy, replacing the first 71
codons plus start codon with the Tau/LacZ sequence (Callahan and Thomas, 1994)
(Saueressig et al., 1999).
Generation of the En2-deficient mice has been described elsewhere (Joyner et al.,
1991). The two lines were crossbred and maintained in an En2-/- background, so that
three possible genotypes occurred (En1 +/+, En1 -/-, En1 +/-). The En1/En2
homozygous mutant dies at P0. At E12 it is easily detectable by a missing cerebellum
(see (Simon et al., 2001; Wurst et al., 1994) for description).
Sur1 mutant mice were generated using the 5’ end of the gene to construct a targeting
vector replacing exon 2 of the gene with a puromycin resistance cassette (Seghers et
al., 2000).
2.1.1 Genomic DNA extraction
Tail biopsies from 2-3 weeks old mice were obtained and stored at –20°C. The tissue
extraction was digested overnight at 55°C in proteinase K buffer [50 mM Tris pH 8,
100 mM EDTA, 100 mM NaCl, 1% SDS supplemented with 5 mg/ml proteinase K
(Applichem, Germany)]. Supernatant was added to equal volume of 1:1
Phenol/Chloroform, mixed and shortly centrifuged. The upper phase was used for
DNA precipitation, which was performed in high salt solution. 1/10th volume 5M
NaCl and 1/2 volume 100% ethanol were added, the mixture was shaken vigorously
and incubated for a minimum of 20 minutes at –80°C. The solution was then
centrifuged for 20 minutes at room temperature. Precipitated DNA was rinsed with
70% Ethanol and then resuspended in 100-500µl TE (10 mM Tris pH 8, 1mM
EDTA). The solution was heated at 65°C from two hours to overnight to further
resuspension of the DNA and then used for PCR genotyping. Alternatively, the
GenElute Kit (Sigma, Germany, Cat.: G1N70) was used according to manufacturers
instructions. In brief, 200µl 100% Ethanol was added to 500µl Proteinase K digested
lysate and transferred to pre-washed GenElute columns. After a short centrifugation,
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the columns were washed twice and the DNA was eluted with 200µ l of the
appropriate Elution buffer.
2.1.2 Primers and PCR settings for genotyping
The genotyping for En2 wild type and mutant alleles was performed by PCR
containing three primers, the common primer, TTGAGAAGAGAGGCCCTGTA, the
wild type primer, specific for the En2 homeobox, CTGGAACAAAAGGCCAGTGT,
and the mutant primer, TCTCATGCTGGAGTTCTTCG in the neomycin gene (which
only occurs in the mutated allele).
For En1, the primers for detecting the knock-in Tau-LacZ allele were
GTGTCCGGCAGCTTGGTCTT on  t he  Tau -LacZgene ,  and
TTCGCTGAGGCTTCGCTTTG, starting at position 224 of the exon 1.
For Sur1, the primers for detecting wild-type alleles were
AGGTTGTTGGTGGAGGTCAG and CCAACACGAGCCTTGAACTT. For
detecting knock-out alleles,  AGGTTGTTGGTGGAGGTCAG and
GCTACTTCCATTTGTCACG were used.
The PCR settings for En2 and Sur1 were 5 min at 94°C, 45 sec at 94°C, 1 min at
54°C, 1 min at 72°C, 35 cycles, 5 min at 72°C.
For En1 they were 5 min at 94°C , 45 sec at 94°C, 1min at 54°C, 1 min at 72°C, 30
cycles, 5 min at 72°C.
The PCR mix in all cases consisted of 2.5 mM MgCl2, 10x buffer, 1 mM dNTP and
2% primer mix and 1% Taq polymerase (all from Fermentas, Germany) plus 1-3 µl
DNA (2% of the total volume).
Figure 2.1:
Primers used for
genotyping
En2 common primer TTGAGAAGAGAGGCCCTGTA
En2 wild type primer CTGGAACAAAAGGCCAGTGT
En2 mutant primer TCTCATGCTGGAGTTCTTCG
En1 mutant primer tLacZ GTGTCCGGCAGCTTGGTCTT
En1 mutant primer exon1 TTCGCTGAGGCTTCGCTTTG,
Sur1 wild type primer A AGGTTGTTGGTGGAGGTCAG
Sur1 wild type primer B CCAACACGAGCCTTGAACTT
Sur1 mutant primer A AGGTTGTTGGTGGAGGTCAG
Sur1 mutant primer A GCTACTTCCATTTGTCACG
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2.2 Primary cell culture
2.2.1 Coating of coverslips
Cover slips were dipped into 96% EtOH, ignited and then put into 24 well plates.
500µl of 0.01mg/ml Poly-ornithin (Sigma, Germany) was added per well and
incubated for one hour. The poly-ornithine was removed, the cover slips were washed
three times with sterile H2O and 1mg/ml Laminin was added in F12:DMEM
(Cambrex, Belgium) at a 1:1000 ratio. The cover slips were incubated for at least two
hours.
2.2.2 Culture
Pregnant mice twelve days post coitum (day of vaginal plug = E0) were sacrificed
using CO2, the body was dabbed in 70% ethanol to prevent fur from contaminating
the uterus. The uterus was taken out in toto and placed in a plate containing ice-cold
Leibovitz’s F15 medium (Cambrex, Belgium). The embryos were collected and, in
the case of engrailed 1 mutants, genotyped. Detecting the En1 mutation was
accomplished by incubating toes from sacrificed mice in Xgal Solution containing 5
mM K3Fe(CN)6 (Sigma, Germany), 5 mM K4Fe(CN)6_3H2O (Sigma, Germany), 2
mM MgCl2 and with 1 mg/ml X-Gal (AppliChemGmbH, Germany) for 30 min at
37ºC.
The midbrain was taken out, the meningis was removed and the ventral part of the
mesencephalon was placed into a tube containing ice-cold Leibovitz’s F15. Brains
were pooled according to genotype. After all samples were collected, the medium was
removed and a 0.25% Trypsine/EDTA solution (Invitrogen/Gibco, Germany) was
added. The tubes were incubated for ten minutes at 37°C, after which the trypsine was
removed and the tissues were washed with 1:1 medium/FCS. The solution was
removed and 500µl fresh medium was added. A fire-narrowed glass pipette was used
to separate the cells from each other by triturating the cell solution gently up and
down. The cells were centrifuged down (3200 rpm) 10 minutes (Beckmann TL, Rotor
TLS 55), the medium was removed and fresh medium was added. The cells were
pipetted up and down to distribute the cells equally in the solution and then were
plated out. For each brain in the pool, five 10mm cover slips were used (amounting
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for roughly 150000 cells per slip). The cells were diluted so that 100 µl per slip were
used.
Each cover slip was placed on a separate holder and incubated for one hour at 37°C,
to let the cells settle and attach to the surface. After this hour, the cover slips were
placed in 24 well plates, 500 µl medium was added and after 24h, another 500 µl.
2.2.3 Neurotoxins used on primary cell culture
Ventral mesencephalic culture was first cultured for two to five days. One day before
toxin insult, the medium was changed to serum-free medium. One hour before toxin
insult, cells were pre-incubated with 1 mM tolbutamide, 10 mM TEA or 100 µM
pinacidil. Cells were exposed to 10 µM MPP+, 40 nM rotenone (both Sigma,
Germany) or 200 µM 6-OHDA (Invitrogene, Germany) for 24 h, after which the
medium was removed, cells were fixed with 4% PFA and stained (see
Immunohistochemistry)
2.2.4 Medium used for primary cell culture
DMEM/F12 with 1 % glutamine (Invitrogen, Germany)
1 % PenStrep (50 U/ml Penicilin, 50 µg/ml Streptamycin)
5 % FCS (10% for E18 cultures)
0,36 % Glucose (=33 mM, Sigma, Germany)
0.25 % BSA (Sigma, Germany)
1% N2-supplement (500 µl N1 supplement + 200 µl Insulin, Invitrogen, Germany)
In case of serum-free medium, the medium was the same as above, but lacking FCS.
2.3 Implantation of osmotic minipumps
All operations were done according to the guidelines of German animal handling law.
Postnatal day 15 (P15) mice were anesthetized with isofluran (2-5 vol% in O2). The
area of the lower head to upper back was shaved. The osmotic mini-pump (1002D,
Alzet, USA) was filled with 100 µl of either tolbutamide, glibenclamide (both diluted
in DMSO) or DMSO alone. The PE tubing of the Brain Infusion Kit 3 (Alzet, USA)
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was filled with the respective solution to prevent air bubbles and attached to the
pump. The length of the tubing was determined with the growth of the mouse in mind
(ca. 2 cm).
An incision was made along the midline of the head, starting right behind ear level
down to the neck. The skin was pulled away from the incision and the bone of the
skull was dried with a cotton tip; a pocket under the skin on the back of the mouse
was formed using the blunt plastic cap of a syringe. A needle was used to drill a hole
in the skull roughly 1 mm from both the line of Bregma and the midline. The pump
was put into the pocket and the cannula was placed into the drilled hole and held until
the Loctite glue had dried. The skin was closed with a suture, occasionally, a wound
clip or tissue glue was added as an additional precaution. After a subcutaneous
injection of 100 µl (5 mg/ml) of the analgesic Carprofen (Pfizer, Germany), the mice
were allowed to regain full consciousness in a separate cage. After normal behaviour
(grooming, exploration etc.) was seen, the mice were put together in the cage with the
mother and the rest of the litter. On the next morning all operated mice received
another injection of the analgesic. The mice were screened for abnormal behaviour,
pain, open sutures, weight loss etc. from then on for two to four weeks until sacrifice.
In the case of open sutures, mice were anesthezised again and the suture was closed.
The mice were weaned from the mother one week after the operations but kept
together with littermates. Animals which were exposed for four instead of two weeks
were operated again to change the pump. Those animals were anesthesized and a
small incision was made on the back were the pump was situated. The pump was
detached from the tubing, a new pump was attached and the wound was closed with
wound clips. The animals were killed after two or four weeks after the operation and
treated as described in the next section.
Adult wild-type mice were treated in a similar fashion, the only difference being the
model of the pump (1007D, Alzet, USA), which has an operating range of one week.
After the operation the mice were allowed to recover for two days, after which they
were injected with MPTP (20 mg/kg) once every day.
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2.4 Preparation of postnatal mouse brain sections
Postnatal day 0 (P0) animals were anesthetized on ice for 3 minutes, the breast was
opened and the heart was perfused with 4% PFA. Older mice were killed using CO2
and treated the same. The skull was opened and partly removed, the brain was taken
out in toto. Following this, the tissue was fixed in 4% PFA over night and
cryoprotected by incubation with 30% sucrose solution over night.
The brains were embedded in OCT Neg-50 Cry-medium (Microm) and sectioned on a
cryostat (Microm). Sections of 50µm or thicker were taken up in 24 well plates
containing PB and all subsequent steps were done with floating sections. Sections of
14 to 25µm were taken up on Superfrost/Plus Adhesion Microscope slides (NeoLab,
Germany).
2.5 Immunohistochemistry
Sections were blocked using a PB solution containing 10% heat-inactivated FCS and
1% Triton. After one hour, the blocking solution was removed and the primary
antibody with blocking solution was added. Incubation was carried out at 4°C over
night. Sections were washed three times with PB and secondary antibody in blocking
solution was added 1:500 and incubated either for four hours at room temperature or
over night a 4°C. Sections were washed three times in PB and incubated with either
1:500 streptavidin-horseradish peroxidase for DAB colour reaction or streptavidin-
Cy2 for fluorescent stainings (both Dianova, Germany). 0.5 ml DAB (Sigma,
Germany) solution was diluted in 10 ml PB (=0.05%), 3.3 µl H2O2 per 10 ml was
added. Solution was put in each well (in case of 24 well plates) or on cover slips (in
case of sections). Cells/Sections were developed to satisfaction and then washed twice
with PB. Cover slips with cells were put cell-side down on a cover slip on a drop of
aqua-polymount (Polyscience, Germany) and counted. Sections were dehydrated in an
ethanol series (30%, 60%, 90% and absolute) and 2x in Xylol for five minutes.
Sections were then overlaid with DPX (Sigma, Germany) and counted.
Primary antibodies used:
1:1000 Rabbit α-TH (AB152, Chemicon, Germany)
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1:250 Rabbit α-Pbx1/2/3 (Santa Cruz, USA)
Secondary antibodies used (all Dianova, Germany):
1:1000 Goat α-rabbit-biotin
1:1000 Streptavidin-horse radish peroxidase
2.6 Cell counting procedures
Stained cells were counted under a common light microscope at x20. Cover slips were
slowly moved from side to side and the resulting lanes at the widest expansion
through the objective were counted to make sure that all cells were only counted once.
Tiny irregularities of the edge of the cover slips were used as landmarks when the
cover slip was moved up to the next lane, so that no cell was counted twice.
2.7 Data management and statistics of primary cell cultures
Cell numbers obtained from cover slip countings were pooled per condition tested.
Percentages of cell survival were first calculated by dividing a cell count by the
respective average control cell number for that specific experiment. From these
percentages, an average effect for the condition was calculated. The effect of
tolbutamide, TEA and pinacidil on toxins was normalized against the average effect
of the drug alone. Standard error of mean was calculated from normalized data, where
applicable. P-values were calculated by using the total data from normalized
conditions and toxin alone, using a two-tailed Student’s t-test. P-values below 0.001
were considered significant.
2.8 Image processing
All images were captured with a CoolSnap camera (Photometrics, Germany) through
a Zeiss Axiophot, a Leica Macrophot, or a Leica TMS MP Multi Photon Confocal
microscope and processed using Phylum 2.6.1 and Adobe Photoshop 7.
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2.9 Additional methods applied in chapter 4: Miscellaneous Results
2.9.1 Cloning of a HNF3a/Foxa1 flox plasmid
The method to obtain specific genomic DNA fragments to generate a viable knock-in
plasmid has been described recently, a one-step cloning process (Scholz et al., 2006).
2.9.1.1 Database search for Foxa1 cloning
Mouse Genome Blast at http://www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html,
default settings – Database = genome, Program = blastn, use MegaBLAST, Expect =
0.01, Filter = default, Descriptions = 100, Alignments = 100. In some cases, the
MegaBLAST option was removed and the Filter option set to “none” to determine the
location of BAC end sequences. The accession numbers for the mouse genes used for
the database searches: Deleted in Colorectal Carcinoma (DCC) NM_007831,
Dopamine Receptor 2 (Drd2) NM_010077, engrailed-1 (En1) NM_010133, Foxa1
NM_008259, Nerve Growth Factor Receptor 1 (Ngfr or p75) NM_033217 and Pbx1a
NM_183355.
2.9.1.2 Programs used for in silico cloning
Gene Construction Kit 2.5 (SciQuest, USA) for generation of the restriction maps and
the virtual assembly of vectors and inserts before designing primers. Oligo 6.8 from
(Molecular Biology Insights, Inc., USA) to search for appropriate primers. The search
for primer pairs was always performed at highest stringency. All of the chosen primer
pairs had a suggested annealing temperature of 55°C or higher.
2.9.1.3 PCR conditions and restriction digests for BAC cloning
The BAC clones were all purchased for a nominal fee from the Children's Hospital
Oakland Research Institute, USA, (http://bacpac.chori.org). All used restriction
enzymes are commercially available. The ligations were performed with the TaKaRa
Ligation Kit Version 2 (BioWhittaker, Germany) at 16°C for at least 30 min. The
PCR reactions were all done with standard solutions (PCR buffer with NH4SO4
(Fermentas); 12.5 µM dNTPs (Roche Diagnostics); 1.5 mM MgCl2 (Fermentas));
PCR settings were one cycle of 5 min at 94 °C, followed by 20-25 cycles with 30’ at
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94°C, 60’ at 55°C or higher (determined by primer set used), 45’ at 72°C and a final
step of 7 min at 72°C.
2.9.1.4 Cell culture of ES cells
One 6 cm plate and sixteen 9 cm plates of growth-inhibited MitoC treated feeder cells
were prepared for growing ES cells until electroporation and for G418 selection after
electroporation. 24 h before ES cells were plated on MitoC feeder plates, the medium
was changed from feeder medium to ES cell medium. One vial containing TBV-2 ES
cells was quickly thawed at 37°C and then transferred to ES cell medium. The cells
were pooled by a centrifugation step at 1000 rpm for five minutes, then were
resuspended in 5 ml of fresh medium and plated out on a 6 cm MitoC feeder plate.
The medium was changed at exact intervals of 24 hours to keep the cells in
synchronized division. The cells were grown to confluency and then splitted with
0.03% trypsine in a 1:6 ratio to the 9 cm plates. The medium was changed two hours
prior to every trypsination. Before electroporation, eight 9 cm plates were coated with
a 0.1% gelatine solution for 20 minutes. The plates were then air-dried. The medium
of three of the ES cell plates was aspirated and the plates were washed twice with
PBS before they were trypsinized. A Pasteur pipette was used to break up cell clumps
with gentle pipetting. Cells were pooled, spun down and resuspended in 20 ml ES
medium, of which 10 ml was transferred to each of two gelatine plates. The cells were
incubated at 37°C for twenty minutes. The supernatant containing the ES cells (which
don’t attach themselves as readily as the feeder cells) was transferred to a second set
of gelatine plates. After that the process was repeated with the other 3 ES cell plates
and all ES cells were finally pooled and counted.
At least 20x106 cells were used per electroporation. ES cells and NotI-linearized DNA
construct were taken up in 0.7 ml ice-cold PBS and put into an electroporation
cuvette. Electroporation took place with a 240 V pulse at 500 µF. The cuvette was
kept on ice for twenty minutes afterwards. The cell slurry was re-suspended in 100 ml
ES cell medium and spread evenly over ten 9 cm Mitoc treated feeder plates.
After 24 hours, the medium was changed to Neomycin-containing ES medium
(350ug/ml Neomycin) and changed every 24 hours afterwards. After ca. four days, the
selection started, visible by ES cell colonies dieing. After selection in G418
(Neomycin) containing medium for ten days, cells on electroporation plates had
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colonies of surviving ES cells. Twelve hours before picking clones, MitoC treated
feeder cells were placed into flat-bottomed 96-well plates. Two hours before picking,
the medium on the ES cell plates was changed and a number of 24 well plates was
gelatine-coated. The plates were washed twice with PBS and then put under PBS with
Pen/Strep. Colonies were picked with the help of sterile 200 µl tips and a binocular
light microscope. Only colonies containing undifferentiated cells were picked. Cells
were put into the 96 well plates (propagation) as well as into the 24 well plates (DNA
for analysis). Medium on both types of plates was changed every 24 hours. Special
effort was made to freeze cells of the 96 well plates before they started to
differentiate. Plates were frozen for one hours  at –20°C, and stored at -70°C in 12.5%
DMSO, 25% FCS in ES medium.
2.9.1.5 Genomic Southern Blots
About 10 µg of DNA was digested over night. The samples were run on a 0.7%
agarose gel overnight at 25-28 V, 70-80 mA or six hours at 35 V. Gel was
equilibrated and blotted with 0.4 M NaOH on Zeta-Probe GT Genomic Tested
(BioRad, Germany) over night. The membrane was washed twice in 5X SSC and then
dried.
The rediprime II random prime labelling system (GE Healthcare, Germany) was used
according to manufacturers instructions. 2.5 to 25 ng of Probe DNA in 45 µl 10 mM
Tris HCL pH 8.0, 1 mM EDTA (TE-buffer) was used. Probes were heated at 95°C for
five minutes, snap-cooled on ice for five minutes and centrifuged briefly. Afterwards,
5 µ l of Redivue 32P dCTP (= 50 µCi) (GE Healthcare, Germany) was added and
mixed until the solution was completely purple. The tube was incubated at 37°C for at
least ten minutes. The membrane was pre-incubated with QuikHyb mix (Stratagene)
for twenty minutes. 14-15 ml QuikHyb were preheated to 68°C. The probe was
denatured as above and added to preheated mix. Membranes were incubated on a
rotator for at least one and half hours to a maximum of three hours
Post-Hybridization washes were 2x SSC/0.1x SDS RT five minutes, 0.1x SSC/0.1x
SDS at 68°C for 30 minutes and 0.1x SSC/0.1x SDS at 68°C for 30 min. A final wash
with VE water was done to reduce salt residues and background. Membranes were
wrapped with saran wrap and exposed on film for 2-4 hours or overnight, depending
on strength of signal.
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2.9.2 Pet-1 DIG in situ hybridization on whole mount
E12 mouse embryos where immersion-fixed in 4% para-formaldehyde and stored in
100% methanol at -20°C. The digoxigenin (DIG)-labeled Pet1-specific antisense
RNA probe was prepared using a 1 kb fragment of the mouse Pet-1 cDNA encoding
an unconserved region of the Pet1 protein downstream of the ETS domain (Hendricks
et al., 1999). DIG-Pet1 probes were synthesized according to manufacturer’s
instructions (Roche, Germany). Embryos were re-hydrated, treated with 10 mg/ml
Proteinase K for ten minutes, and post-fixed in 4% paraformaldehyde/0.1%
glutaraldehyde for twenty minutes. Hybridization was carried out over night at 70°C.
Embryos were washed, blocked with 10% sheep serum for two hours, and incubated
over night at 68°C with anti-DIG antibody (Roche, Germany) 1:10.000 in 10% sheep
serum. Color reaction was carried out using NBT/BCIP (Roche, Germany).
2.9.3 En1/Pbx1a Tetracycline inducible expression vectors
The generation of En1/Pbx1 TetON N2A cells has been described elsewhere (Paola
Sgado, Univ. Diss., Heidelberg, 2006, IX, 118, XLII Bl). In brief, inducible
expression was achieved with the use of the RevTet-On Expression System
(Clontech, Germany). In order to obtain stable transduced cell lines a retroviral vector
based strategy was chosen. The Tet Systems are based on two elements from the tet
operon of the E. coli Tn10 transposon: The Tet repressor protein (TetR) and the tet
operator DNA sequence (tetO). The gene of interest is cloned into the pRevTRE
response vector downstream of the tetracycline-responsive element (TRE), which
contains seven direct repeats of the 42-bp tetO sequence and the minimal immediate
early promoter of cytomegalovirus (PminCMV). G418 resistant Neuro2a
neuroblastoma cells expressing the reverse tetracycline-controlled transactivator
(rtTA) were kindly provided by M. Wegner, Nuernberg (Peirano and Wegner, 2000).
Stable transfection of retroviral TRE vector carrying En1-IRES-Pbx1a genes was
performed using calcium phosphate precipitates and hygromycin selection. The stable
transfected Neuro2a population was splitted up into single cell clones. Single clones
were then analyzed by PCR and immunocytochemistry and selected based on the
correlation between expression of the gene of interest in presence and absence
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(background expression) of tetracycline (induction/background ratio). The resulting
clones were maintained in DMEM containing 10% serum, G418 (300 µg/ml; Gibco
BRL) and hygromycin (300 µg/ml; Gibco BRL).
2.9.4 ChIP assay
En1/Pbx1a Tet-induceable cells were grown to near confluency in 5% FCS containing
OptiMEM (Gibco, Germany). Cells were induced with 5 mg/ml doxycyclin solution
for two days. Cells were fixed with fresh 1% formaldehyde at 37°C for ten minutes.
Cells were washed with PBS containing protease inhibitors and then incubated with
lysis buffer. The solution was sonificated to achieve DNA lengths between 200 and
1000 bp. Solution was transferred to ChIP Dilution buffer (Upstate, USA) and
preincuabted for 30 minutes with 60 µl Salmon Sperm DNA/Protein A agarose slurry
(Upstate, USA). Solution was incubated over night with 1:250 rabbit α-Pbx1a
antibody (Santa Cruz, USA). Solution was then incubated with 60 µl Salmon Sperm
DNA/Protein A agarose slurry and centrifuged. The slurry was washed with Low Salt,
High Salt and LiCl Immune Complex Wash Buffers and twice with TE (all Upstate,
USA). 250 µl elution buffer (1% SDS, 0.1 M NaHCO3) (Upstate, USA) was added to
slurry and incubated for 15 minutes. Supernatant was pooled with second elution. 20
µl NaCl was added to supernatant and incubated for four hours at 65°C to reverse
histone-DNA binding. 2 µl of 10 mg/ml Proteinase K was added in 30 µl TE to
solution and incubated for one hour at 45°C. DNA was then precipitated by column
(GenElute, Sigma, Germany). Samples were run at a nested PCR under standard
conditions (see e.g. engrailed 2 PCR conditions, above).
Outer primers AAGTGTCCAGGGATCTAATTC +
TCTGCCACTCCTAACTCACA
= fragment size 567bp
Inner primers GTTTTCCTCTCTTGGG +
CTACTTGCCTATGAGGTACAT
= fragment size 209bp
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3 Results
The results are composed of five parts. First, I established non-toxic conditions for the
drugs tolbutamide, tetraethylammonium (TEA) and pinacidil on primary ventral
midbrain cell cultures of E12 mice. Then, the effect of these agents on mesDA
neurons in primary cultures treated with the toxins MPTP, rotenone and 6OHDA is
shown. Second, evidence is presented of a rescue of the progressive EnHT nigral
phenotype by the ablation of Sur1 expression. Preliminary results in the third section
deal with an implantation of osmotic minipumps containing tolbutamide and
glibenclamide, another KATP channel blocker into P15 EnHT mice, to stop the
progressive nigral DA cell loss these animals develop. The fourth part shows results
of similar implantations into adult wild-type mice, followed by sub-acute MPTP
treatment.
In the last part, I discuss miscellaneous results obtained and published during my
work, first, a novel one-step cloning technique for isolating defined DNA fragments
of various genes from a larger DNA source, which in my case were bacterial artificial
chromosomes (BACs). In a direct application of this technique, a loxP knock-in
construct of exon 2 of the Foxa1 gene was designed in silico, the necessary DNA
sequences from three BACs were isolated and used to generate ES cells carrying the
knock-in gene. Furthermore, I investigated the requirement of the engrailed genes in
the development of the noradrenergic neurons of the locus coruleus and locus
subcoruleus and the serotonergic neurons of the median and dorsal raphe nuclei.
At the end, a ChIP (ChromatinImmunoPrecipitation) assay to investigate the possible
binding of Pbx protein to the promotor region of AADC was performed and an
analysis of Lmx1b heterozygous mutant mice to study possible gross changes in
mesDA cell number and distribution.
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3.1 Pharmacological treatment of primary mouse ventral midbrain cultures
In recent experiments performed in my lab, primary cultures of E12 mouse ventral
midbrain cells were treated with sub-acute doses of the toxins MPTP, rotenone and 6-
OHDA to induce partial neuron loss. Pre-incubated with 1 mM of the KATP channel
blocker tolbutamide, the primary cultures treated with rotenone were partially
rescued.
To further investigate the effect of the state of KATP channels on the survival of
mesDA neurons under conditions of oxidative stress, I expanded these experiments
and used tolbutamide, the KATP channel opener pinacidil and an additional potassium
channel blocker, TEA (Tetraethylammonium). TEA is binding to a wide range of K-
channel subtypes on the plasma membrane and directly blocks the pore of the
channel, whereas pinacidil binds to the Sur part of the channel and activates channels
on the plasma membrane and channels present on the inner mitochondrial membrane.
In addition to rotenone, two other toxins were used. MPTP and 6OHDA are taken up
specifically by dopaminergic neurons and like rotenone, cause DA cell death
predominantly by inhibition of the respiratory chain.
3.1.1 Culture system and concentrations for drugs and toxins
The system used for study of the effect of toxins and KATP channel drugs were
primary cultures of E12 wild-type embryos. In order to prepare these cultures, in
brief, E12 embryonic brains were dissected, the ventral mesencephalon was pooled
from all animals of one litter, trypsinized and plated homogenously on poly-
ornithine/laminine coated cover slips under DMEM:F12 medium. The cultures can be
used in a time window between one day and two weeks. During the second week,
several still dividing cell types will start to grow into colonies and cover the plated
cells. In order to rule out secondary effects of these clusters depriving underlying
mesDA cells and causing unspecific cell death, only cultures of less than one week of
age were used for experiments. After one day, the non-dividing mesDA neurons had
formed neurites and were easily detectable after TH-immunostaining, as single cells
or small groups of three to five cells. The number on each cover slip per prepared
pool of cells ranged from 150 to 600 cells between experiments. The cells were
counted under a light microscope (as described in Materials and Methods). Every
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condition was tested on at least three, on average on five cover slips per experiment.
Per condition, at least 13 cover slips were counted in a minimum of three separate
experiments.
As a first step, different concentrations of each drug were tested for their toxicity by
using gradients. For the KATP channel blocker tolbutamide, the concentrations used
were 500 µM, 1 mM and 2 mM. For the KATP channel opener pinacidil concentrations
from 1 µM, 100 µM and 500 µM were tested and for the unspecific plasma membrane
potassium channel blocker TEA 1 mM, 10 mM and 25 mM. A small amount of cell
death caused by pinacidil, tolbutamide or TEA was tolerated in order to guarantee a
maximal effect of the drug.
These gradients established the concentrations for each subsequent experiment of
tolbutamide at 1 mM, of pinacidil at 100 µM and of TEA at 10 mM.
Sub-acute doses of MPTP (10 µM), rotenone (40 nM) and 6OHDA (200 µM) were
used to generate an incomplete rate of cell death, in which the cells could still react to
outside cues. Cell cultures in serum-free medium were pre-incubated with the
respective drug for one hour, then the toxin was added and the cultures were
incubated for 24 hours. 6OHDA was added for only 15 minutes and the medium was
then exchanged with fresh medium containing the drug. After incubation, cultures
were PFA-fixed and immunohistochemically labelled for TH. The stained cells were
counted under a microscope. The counted number of surviving cells for (toxin + drug)
effect were corrected against drug alone (see data management & statistics in Material
and Methods).
3.1.2 Tolbutamide alleviates rotenone-induced cell death
Tolbutamide is not readily soluble in water and was dissolved in DMSO before use.
2.5 µl of a 185 mM stock solution were used to pre-incubate each of the respective
cover slips. Upon addition of tolbutamide, the plates were stirred gently to facilitate
an even distribution of the drug.
After pre-incubation with 1 mM of this KATP channel blocker cell survival on
rotenone treated cells of E12 mesDA primary cultures was increased significantly by
21% (p=0.00047) (the survival rate increased to 56%±4; (rotenone control (35%±3)).
1 mM tolbutamide had no effect on MPTP-treated cells (survival rate 40%±4; (MPTP
control (41%±5))).
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It had a slightly negative effect on 6OHDA treated cells (survival rate 71%±4;
(6OHDA control (82%±5))), however this was not statistically significant
(p=0.71602).
The differential effect of tolbutamide on the cultures treated with the three toxins
suggests that the molecular mechanism leading to cell death is different between these
models.
Figure 3.1: Effect of tolbutamide treatment on toxin insults
Percentage of cells surviving in primary cultures of E12 mouse ventral mesencephalic dopaminergic
neurons after toxin and tolbutamide treatment. 1 mM tolbutamide had a slight but insignificant effect
on 6OHDA treated cultures. Tolbutamide had no effect on MPTP treated cultures, but it increased the
amount of surviving cells after rotenone treatment by 11% (p=0.00047). n = 13 to 21, asterisk marks
significance
3.1.3 TEA has a positive effect on both rotenone and MPTP treated cells
In order to elucidate a possible specific effect of KATP channel blockade on cell death
from a possible unspecific effect of impairing K+ flux across the cell membrane or the
effect of other potassium channel types, 10 mM of the unspecific potassium channel
blocker TEA was used on primary E12 ventral midbrain cultures treated with all three
toxins. TEA is soluble in water and was here dissolved in serum-free medium.
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TEA enhanced cell survival after rotenone treatment significantly by 16%
(p=0.00128) (the survival rate increased to 51%±3; (Rotenone control (35%±3))).
TEA had an even stronger effect on MPTP treated cells, the rate of cellular survival
was raised significantly by 33% (p=0.00013) (the survival rate was increased to
72%±5; (MPTP control (41%±5))).
Figure 3.2: Effect of TEA treatment on toxin insults
Percentage of cells surviving in primary cultures of E12 mouse ventral mesencephalic dopaminergic
neurons after toxin and TEA treatment. 10 mM TEA increased cellular survival very slightly by 8% on
6OHDA treated cells. TEA had a significantly increased cell survival on MPTP treated cells by 33%.
Similarly, TEA enhanced cell survival after rotenone treatment by 16% to 51%±3. n=16 to 21, asterisk
marks significance
TEA had only a very slight effect on 6OHDA treated cells and increased cellular
survival by 8%, however, this effect was not significant (p=0.32580)
(survival rate 90%±6; (6OHDA control (82%±5))).
Thus, TEA enhances cell survival in the MPTP and rotenone assays, possibly by
either affecting other potassium channels aside from KATP channels, by providing a
more thorough blockade of KATP channels than tolbutamide or by being more resistant
to degradation processes than tolbutamide.
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3.1.4 Pinacidil enhances cell death in all toxin assays tested
Since blocking of KATP channels enhanced cell survival of mesDA primary cultures, I
wanted to know whether the KATP channel specific opener pinacidil would decrease
cell survival in these assays. This question is even more interesting considering the
well established role of a positive effect of KATP channel activation in conditions of
cellular stress like hypoxia. Primary cultures of E12 ventral midbrain cells were
treated with 100 µM pinacidil under the established toxic conditions of 200 µM
6OHDA, 10 µM MPTP or 40 nM rotenone, to investigate whether this would
exacerbate the rate of cell death.
Figure 3.3: Effect of pinacidil treatment on toxin insult
Percentage of cells surviving in primary cultures of E12 mouse ventral mesencephalic dopaminergic
neurons after toxin and pinacidil treatment. After pre-incubation with 100 µM pinacidil, the survival
rate on 6OHDA treated cultures dropped by 33%, on MPTP treated by 11% and on rotenone treated
cultures by 20%. n= 15 to 21, asterisk marks significance
This was indeed the case, pinacidil enhanced the amount of cell death under all three
toxic conditions.
The effect was the most severe on 6OHDA primary cultures. Here the survival rate
dropped by 33% (p=0.00001). (Survival rate was 49%±5%; (6OHDA control
(82%±5))
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Pinacidil caused a decrease in cell survival on rotenone treated cultures as well. Here
the rate dropped by 20% (p=0.00012). (Survival rate was 15%±3%; (rotenone control
(35%±3)))
The effect of pinacidil on MPTP treated cultures was the least severe and not
significant (p=0.11112). Nevertheless, cellular survival of the mesDA neurons
dropped by 11%.
(Survival rate was 30%±4%; MPTP control (41%±5)))
These results challenge the view of KATP activation as a means to prevent cell death.
Not only is the rate of cell death increased, in comparison to tolbutamide and TEA,
pinacidil has a stronger effect on the amount of cell death/survival and affects cells
treated with all three toxins and not just rotenone (as tolbutamide) or rotenone and
MPTP (as TEA).
3.1.5 Overall influence of drug treatment in toxin models
Given that the three toxins used are all predominantly causing cell death via oxidative
stress, the different effects of tolbutamide, pinacidil and TEA are interesting and
suggest an induction of cell death by distinctively different molecular mechanisms.
The different effects become even more apparent when cell survival rates are
compared to the baseline effect of each toxin. Tolbutamide had a significant effect on
rotenone treated cultures, improving cell survival by 60%. The slight reduction in cell
survival tolbutamide caused on 6OHDA treated cultures is difficult to interpret.
6OHDA is known to have rather broad array of ways to cause cell death, e.g. the
generation of quinones, and its toxicity might not be related to KATP function. TEA
enhanced cell survival on rotenone treated cultures by 44% and by 75% on MPTP
treated cultures. As a rather unspecific blocker of potassium channels, the strong
effect TEA has on MPTP treated cultures might be a sign of a different mode of
apoptosis triggered, which is influenced by blocking other types of potassium
channels. This is further strengthened by the effect of the KATP channel opener
pinacidil. This drug had a significant negative effect on 6OHDA and rotenone treated
cultures, while MPTP treated cultures were relatively unchanged. Cell survival rates
dropped by 41% on 6OHDA treated cultures and by 57% on rotenone treated cultures
when compared to the baseline toxin effect. This is no simple reversal of the effect of
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tolbutamide and channel blocking but suggests that e.g. overall K+ efflux from the
cell due to pm KATP opening or high levels of ROS due to m KATP activation might
lead to a more severe rate of cell death.
Taken together, the negative effect of tolbutamide on 6OHDA cultures, blocking of
KATP channels had a positive effect in the context of oxidative stress of mesDA
neurons, while the activation of KATP channels increased cell death. Other mechanisms
than the production of ROS contribute to cell death and the positive effect of TEA
suggests these mechanisms either do not to involve KATP channels, but possibly other
types of potassium channels or might provide evidence for K+ efflux from the cell.
Figure 3.4: Baseline change of cell survival 6OHDA
Compared to baseline 6OHDA effect, cell survival decreased by 14% for tolbutamide, increased by
10% for TEA and decreased by 41% for Pinacidil, the only significant effect.
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Figure 3.5: Baseline change of cell survival MPTP
Compared to baseline MPTP effect, cell survival increased by 7% for tolbutamide, increased by 75%
for TEA and decreased by 27% for Pinacidil. Both the effect of TEA and pinacidil were statistically
significant.
Figure 3.6: Baseline change of cell survival Rotenone
Compared to baseline rotenone effect, cell survival increased by 60% for tolbutamide, increased by
44% for TEA and decreased by 57% for Pinacidil. All effects were statistically significant.
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3.2 Targeted deletion of Sur1 rescues EnHT mesDA phenotype
Mice carrying a single deletion of engrailed 1 in the background of the full En2
knockout (EnHT), loose the SNpc part of the mesDA neurons gradually, starting at
around P15 and peaking at three months of age. Mice carrying a homozygous deletion
of the Sur1 gene do not express a KATP channel. Previous results from my lab showed
that this viable and fertile mutant has no deficiencies, with regard to mesDA neuron
number, distribution and axonal fibre density. In an attempt to transfer the in vitro
blocking of KATP channels to an in vivo situation, EnHT mice were crossed with Sur1
mice, left to age for at least 90 days, after which animals were sacrificed and stained
immunohistochemically against TH. Sections of mice 19 months and older were
compared on a gross morphological level to EnHT and wild type mice of similar ages.
The additional homozygous deletion of Sur1 in the background of EnHT completely
rescues the loss of the SNpc DA neurons that the EnHT mice develop till P90. A
normal copy of Sur1 (Sur1-/+) is unable to prevent the cell loss. Taken together, this
suggests that the mesDA neurons of EnHT mice undergo apoptosis following a
mechanism which is dependent on KATP activation. As a single copy of Sur1 is not
able to prevent nigral cell loss, the decision is not dose-dependent but probably a
choice point for triggering apoptosis. It is also possible that the deletion of a single
Sur1 allele is able to slow the SNpc neuronal degeneration. However, in order to
elucidate this, animals of a younger age need to be compared to matched EnHT
controls.
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Figure 3.7: Nigral DA neuron loss is not rescued in Sur1-/+;EnHT mice
Coronal view adult mouse brain on the level of the SNpc. MesDA neurons are visualized via TH
immunostaining. (Sur1-/+; EnHT) While the TH staining shows fibers in the shape of the SNpc, there
are only few cell bodies. (EnHT) As with Sur1-/+; EnHT, the neurons in the SNpc are reduced in number.
(Wild-type). Normal number and distribution of SNpc neurons. Scale bar is 1mm, dorsal is up.
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Figure 3.8: Sur1-/-;EnHT mice have wild-type like SNpc
Coronal view adult mouse brain on the level of the VTA. MesDA neurons are visualized via TH
immuno-staining. Sur1-/-;EnHT mice show a normal number and distribution of DA neurons ins the
SNpc. EnHT mice show an almost complete lack of SNpc DA neurons. Scale bar is 1mm, dorsal is up
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Figure 3.9: Sur1-/+;EnHT and Sur1-/-;EnHT mice have a normal VTA
Coronal view adult mouse brain on the level of the VTA. MesDA neurons are visualized via TH
immuno-staining. All animals show a normal number and distribution of VTA DA neurons. Scale bar
is 1mm, dorsal is up
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3.3 Preliminary results on engrailed mice and KATP channel action
As a second in vivo model to validate the data from both the cell culture and the Sur1-
/-; EnHT mice, I investigated the effect of tolbutamide and another KATP channel
blocker, glibenclamide on young EnHT mice. In order to compare the amount of cell
death occurring in the SNpc of P15 EnHT mice to EnHT mice in which a KATP channel
blocker had been pumped into the brain for two or four weeks (starting at P15) and
because both blockers are not able to pass the blood-brain barrier, it was necessary to
use osmotic mini-pumps (Alzet, USA). The pumps were connected via PE tubing to a
cannula puncturing the skull and reaching into the lateral ventricle of the pup. The
concentrations of tolbutamide (250 µg/day) and glibenclamide (1µg/day) in this
experiment was calculated using known clearance rates of both drugs in human
(Spraul et al., 1989; Veronese et al., 1990). We hypothesized that blocking KATP
channels in EnHT mice before they start to loose their mesDA neurons in the SNpc
will have a positive effect on cell survival. P15 litters were genotyped, the EnHT mice
were selected for operation and separated into groups which were implanted with
pumps containing glibenclamide or tolbutamide or into control groups with pumps
containing only the solvent DMSO as a control. Animals were sedated with isofluran
and kept on a heated pad to maintain normal body temperature. The pump was
implanted into a pocket under the skin on the back of the animals, the connected
BrainInfusionKit was then implanted 1mm rostro-lateral of the point of Bregma.
Operational procedures had to be modified for mice of this young age. In brief, the
concentration of isofluran had initially to be higher (5vol%) to successfully put the
mice into deep sedation. Wound clips were not used because the tool for applying the
clips proved to be too crude to guarantee successful wound closure without doing
harm to the animals. Initial concerns that the mother would not accept the pubs back
into the litter after operation were unfounded. Of 33 animals operated, only a single
case of separation was registered and in this case it was likely that the animal was
suffering from a side effect of the operation and was too weak to join the litter.
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Figure 3.10: Implantation of osmotic mini-pumps
(A) Various models of the Alzet pump. In the experiments the top-most model (1002D) was used. (B)
The structure of a pump. 1 = delivery portal; 2 = flow moderator; 3 = impermeable reservoir wall; 4 =
osmotic agent; 5 = semi-permeable membrane; 6 = reservoir (C and D) Intraventricular implantation of
the cannula, here performed on a rat. (C) After a hole is drilled through the skull, the cannula of the
BrainInfusionKit is placed in it. Connected to the cannula is the PE tube leading to the pump. (D) The
cannula is fixed on the skull, here with dental cement; on mice, super-glue can be used. The tubing
disappears under the skin in the pocket where the pump was placed. The upper part of the cannula will
be removed before the skin is closed with wound clips or a suture. (A and B are adapted from
documentation available from Alzet, USA. C and D are stills taken from training videos available from
Alzet, USA)
The pumps were running for two weeks after which the mice were either sacrificed
and dissected or re-implanted with a new pump and left to survive for another 14
days. Unfortunately, the fixation of the cannula (BrainInfusion Kit III, Alzet, USA) to
the skull
was not optimal for mice of this age. In roughly 80% of the operated mice, the
cannula was not attached to the skull anymore after the experimental period.
Furthermore, there was excessive necrotic tissue in the bone around the hole in the
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skull and in the underlying brain tissue. Most likely, the postnatal growth of brain and
skull caused friction between the fixed-in-place cannula and the expanding tissue
around it. In consultations with Alzet representatives, there was no knowledge of any
trials with osmotic pumps on mice of this age, nor any suggestions on how the
problem could be solved. Therefore, this project was modified to use adult mice with
osmotic pumps and cause progressive mesDA cell loss via a sub-acute injection of
several doses of MPTP (see below). Interestingly, adult mice did not loose their
cannulas, nor did any excessive necrosis occur, strengthening my theory about friction
being the problem in P15 mice.
3.4 Pharmacological treatment of wild-type mice with osmotic mini-pumps
Similarly to the rationale and technique described in the previous section, adult mice
were implanted with an osmotic mini pump containing tolbutamide but then injected
with MPTP. Instead of the slow progressive loss of nigral DA neurons in P15 EnHT
mice, here I wanted to cause mesDA degeneration over a short period of time with
MPTP and study the effect of blocking the KATP channels in the brain with
tolbutamide. MPTP can be applied in many concentrations and over various time
frames to cause a faster or more progressive cell loss. I used a sub-acute dose of
MPTP over the course of three days to generate an incomplete cell death tolbutamide
should be able to influence (similar to the primary culture system). The MPTP model
was chosen because of the relative ease it can be applied to rodents (Przedborski et
al., 2001).
The pump and drug were given two days time to establish a stable flux of solution
into the brain. Furthermore, as the animals were given 100 µl (5 mg/ml) of the
analgesic carprofen (Rimadyl, Pfizer, Germany) after the operation, the time was
necessary to provide a wash-out of the system to make sure that no side-effects from a
presence of the analgesic occurred.
On day three, a dose of MPTP (20 mg/kg) was injected intra-peritoneally into the
mice once per day for three successive days. Over the next four days, the mice were
monitored for changes in health and/or weight. On the fourth day after the last
injection, the mice were sacrificed and the striatum was dissected from the brains and
stored for HPLC measurement of the dopamine content. The remaining midbrain was
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immersion fixed in 4% PFA and stored for later use. Of the first set of mice, five out
of six died for unknown reasons. There are common risk factors for adverse effects
known in MPTP treatment that include e.g. the use of certain mouse strains, female
animals and animals younger than four weeks. All these factors could be excluded in
my case as only male animals of three to six months of age were used. However,
injecting animals subcutaneously rather than peritoneally had a positive effect on the
survival rate of mice, most likely due to the delayed uptake of the toxin through the
skin (Przedborski et al., 2001). I was able to operate a second set of mice and
achieved about 60% survival this time. Unfortunately, all animals surviving, except
one, were part of the control group, carrying pumps with the solvent DMSO. The
single animal showed no alteration in the number of mesDA neurons. While it is
known that MPTP treatment may have huge variances in outcome, a single animal is
not enough to say whether the lack of phenotype comes from this variance or an effect
of tolbutamide. Concerning the small number of tolbutamide treated animals which
survived, it can not be ruled out that the general blocking of KATP channels in the
whole brain via tolbutamide generates side effects which might enhance the chance of
death. However, before I could address this issue, the project had to be put on hold
due to safety concerns regarding the housing and injection of the animals.
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4 Miscellaneous Results
4.1 Engrailed genes are required for the development of dorsal raphe
nucleus/locus coruleus (Simon HH, Scholz C et al., 2005)
Aside from their role in the regionalization of the midbrain and being a survival factor
for mesDA neurons, the two engrailed genes were likely candidates for the early
specification of four midbrain/anterior hindbrain cell clusters. The precursor and
mature cells of the noradrenergic locus coruleus (LC) and L. subcoruleus (NSC) and
the serotonergic median and dorsal raphe nuclei (MRN and DRN) lie within the
expression domains of both En1 and En2 (Davis and Joyner, 1988).
4.1.1 Serotonergic and noradrenergic cell loss in EnHT mice
We could demonstrate that the two engrailed transcription factors are necessary for
the proper specification of two of those nuclei, the serotonergic dorsal raphe nucleus
(DRN) and the noradrenergic locus oruleus (LC) in a gene-dose dependent manner.
Brain sections taken from P0 En1-/-, En1-/-;En2-/- and wild type mice were stained
with an antibody against TH to detect noradrenergic neurons and against serotonin (5-
HT) to visualize serotonergic neurons.
Figure 4.1: Comparison of cell numbers between wild type, En1 and En1/2 mutants.
While the number of cells in MRN and NSC are remain unchanged, there is a gene-dose dependent
reduction of cells in the engrailed mutants. (n=2) (second “NSC WT” in D should read “NSC En1”;
adapted from (Simon et al., 2005))
To measure the amount of cell loss between neighbouring MRN and DRN and of the
LC and NSC the cells were counted under the microscope. While the cell populations
of DRN and LC decrease with the number of deleted engrailed alleles, the
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respectively adjacent MRN and NSC are unaffected. This suggests that the both DRN
and LC are generated from a different subset of cells than their neighbouring nuclei.
Furthermore, the gene-dose dependent loss shows that the engrailed genes can
compensate for each other, as had been shown for the development of the mesDA
neurons (Sgado et al., 2006).
4.1.2 Engrailed is required at an early stage of DRN and LC development
To investigate whether engrailed is present in DRN and LC at early stages of
embryonic development, anti-TH and anti-5-HT antibodies in fluorescent
immunostainings were combined with an immunostaining against tauLacZ. tauLacZ
is part of the construct deleting the start codon of the En1 locus in the mutants and
therefore encompasses its wild type expression domain. In fluorescent overlays of the
three stainings, I was able to show that cells of the DRN, located in the periaqueductal
central gray, do not express engrailed at E12. Even at P0, which was the second time
point investigated, they do not express engrailed, though En- and 5-HT-positive cells
are co-localized at these ages.
The noradrenergic neurons of the LC are outside the expression domain of the
engrailed genes at both ages investigated. This suggests that engrailed is necessary for
proper LC and DRN development at a precursor stage rather than for the post-mitotic,
differentiated cells of both nuclei, as has shown to be the case for serotonergic
midline cells in drosophila (Lundell et al., 1996) and mesDA neurons in mammals
(Simon et al., 2001).
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Figure 4.2: Serotonergic neurons of the DRN and noradrenergic neurons of the LC do not express the
engrailed genes at E12 and P0.
Confocal images of sections from E12 (A and B) and P0 En1+/tLZ mice (C–C’’, D, and D’)
immunostained with antibodies against 5-HT (A–C), tyrosine hydroxylase (TH) (D), and β-
galactosidase (β-gal) (A’, B’, C’, and D’). Merged images (A’’, B’’, and C’’). (A–A’’) Coronal section
of E12 embryo at the level of rhombomere 1. 5-HT and β-gal are co-localized but are not co-expressed
by the same cells. (B–B’’) Posterior section of the embryo. 5-HT-positive neurons located outside of
the En1 expression domain. (C–C’’) Sagittal section through a P0 En1+/tLZ brain. DRN neurons are
located in the periaqueductal central gray containing the processes of En-expressing cells. White
arrows in A–C mark examples of two serotonergic DRN neurons that are En1 negative. The yellow
signals in C’’ are processes of En1/tau-LacZ-+ cells and serotonergic neurons overlapping in the Z-
plane of the confocal images. (D and D’) Double labeling of a sagittal section through the locus
coruleus of an En1+/tLZ brain using antibodies against TH (green) (D) and h-gal (red) (E). The TH-
positive neurons in the locus coruleus do not express En1. Dorsal to the top, rostral to the left, scale
bars = 100 µm (Simon et al., 2005).
4.1.3 Deficits of the DRN stem from a loss of precursor cells
Finally, we showed that the deficits in the DRN of P0 engrailed mutant mice are due
to a loss of precursors and not the result of a re-specification event. In-situ
hybridizations with a probe detecting transcripts of the ETS domain transcription
factor Pet1 revealed, on a gross morphological level, a reduced number and
distribution of prospective serotonergic cells in the DRN at E12. This suggests that
the cells are lost in the mutant and have not entered another cell fate. Pet1 expression
precedes the appearance of serotonin for about twelve hours and is essential for the
development of serotonergic neurons in the CNS (Hendricks et al., 2003).
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In wild type mice, it marks the entire extent of the serotonergic hindbrain raphe nuclei
(Hendricks et al., 1999). The noradrenergic neurons of the LC could not be detected
at E12 in En1/2 mutants even though they appear as early as E11 in the posterior
midbrain of the wild type (not shown).
Figure 4.3: Population of serotonergic neurons is diminished as early as E12 in the engrailed double
mutants.
Immunostaining using antibodies against 5-HT (A and B) and in situ hybridizations using riboprobes
against Pet1 (C and D) on flattened hindbrain whole mounts dissected from wild type (C) and En1/2
mutant embryos (D). (A and B) In E12 wild type, bilateral stripes of densely packed serotonergic
neurons (arrow) are located adjacent to the floor plate. These cells will give rise to the DRN and MRN.
In the E12 engrailed double mutant, the domain of 5-HT-positive neurons in the rostral hindbrain is
significantly reduced (arrow), whereas a more caudally located group of serotonergic neurons
(arrowhead) is unaffected. (C and D) Pet1 in situ hybridization reveals the same pattern. A smaller
rostral domain and a normal distribution of Pet1-positive cells caudally indicating that the serotonergic
neurons, which give rise to the DRN are not generated in the En1/2 mutant embryos. The asterisk
marks the midline. Anterior is to the top. Scale bar = 200 µm. Sections in A and B were processed by
HH Simon. Adapted from (Simon et al., 2005).
Taken together, the loss of LC and DRN points to a requirement of the engrailed
genes for the proper development of the two nuclei. Furthermore, since the adjacent
nuclei, the locus subcoruleus and the median raphe nucleus, are unaffected by the
deletion, these nuclei must arise from different pools of precursor cells than locus
coruleus and dorsal raphe nucleus.
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4.2 In silico design and generation of Foxa1 knock-in targeting construct
(technique described in (Scholz et al., 2006))
Foxa1 became focus of our research after the initial differential display experiment
done in our lab. Between ventral midbrains of E12 En1/2 mutant mice, wild type, E14
wild type and adult olfactory bulb, the gene was found to be expressed in both wild
type and engrailed mutant tissue but not in wild-type olfactory bulb, which comprises
an unrelated population of DA neurons (Thuret et al., 2004). In order to determine if
Foxa1 is necessary for proper mesDA development, the number of TH+ cells in the
ventral midbrain of P0 Foxa1 mutant mice (Kaestner et al., 1999) and their axonal
density in the striatum was determined. Furthermore, it was investigated if the
expression of other mesDA specific genes was changed. In both cases, no difference
between Foxa1 and wild-type mice could be detected (unpublished results). The
inactivation of the Foxa1 gene leads to an early death of the affected mice between P2
and P12, caused by hypoglycemia due to down-regulated glucagon levels (Kaestner et
al., 1999). Therefore, a requirement of the adult animal for Foxa1 in the mesDA
neurons might not be visible until later in life, similar to what can be seen in engrailed
mutant mice (Sgado et al., 2006).
To circumvent a Foxa1 requirement in other organs, I generated a construct for gene
targeting, to produce a mouse with loxP (locus-of-X-over-P1) sites flanking exon 2 of
the Foxa1 gene, the same exon targeted in the original full mutant (Kaestner et al.,
1999). LoxP sequences are recoginition sites for the Cre (cyclization recombination)
recombinase. This recombinase recognizes the loxP sites and cuts out the DNA the
loxP sites flank (Orban et al., 1992). By breeding the Foxa1 loxP knock-in mice with
mice expressing Cre under the control of a mesDA specific gene it would have been
possible to obtain mesDA specific Foxa1 mouse mutants.
4.2.1 One step cloning of DNA framents of defined size
The underlying technique to generate the necessary DNA fragments of the Foxa1
gene to clone the knock-out construct makes use of the fact that the mouse genome is
fully sequenced and the sequence published (Gregory et al., 2002). BAC libraries of
human, mouse and rat, each covering the respective genomes more than 10 fold
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(Osoegawa et al., 2000), are stored as individual clones in the Children’s Hospital
Oakland Research Institute (CHORI). The BAC clones comprising the sequences of
interest can be identified by their end sequences (Zhao, 2001; Zhao et al., 2001) via
BLAST search (http://www.ncbi.nlm.nih.gov/BLAST/) (Altschul et al., 1990), and
bought from the CHORI (http://bacpac.chori.org/) for a nominal fee. With the DNA
sequence known, I could map restriction sites to it and plan digests so that the
resulting fragments could directly be used in the cloning of e.g. knock-out constructs.
To obtain said fragments, after restriction digests the whole pool of fragments was
cloned into a standard Bluescript II SK (-) vector (Stratagene).
Figure 4.4: One-step
cloning of BAC
fragments
Example of the strategy
to obtain a defined
genomic fragment from a
BAC clone. Day One:
The BAC clone is cut
with restriction enzymes
flanking the fragment of
interest  (XbaI and
EcoRI). All resulting
fragments are subcloned
into a vector (Bluescript
II SK(-)) which was cut
with the same enzymes.
After  l igat ion and
t ransformat ion ,  the
bacteria are plated out
and grown overnight.
Second Day:  The
individual clones are
picked and subjected to
PCR with one primer
specific for the targeted
DNA fragment, the other
for the vector (T7 +
Primer A and T3 +
Primer B). The positive
c lones  a re  grown
overnight and the plasmid
DNA is isolated at the
third day (Scholz et al.,
2006).
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One day later, I picked colonies and the one carrying the fragment was identified by a
standard PCR using fragment-specific primers plus a primer specific for the T3
promotor on the vector. After the PCR reaction, the positive clones were placed in 1-2
ml of LB medium and incubated over night. On the next day, the plasmids were
purified by cell lysis and precipitation and analyzed by restriction digests.
Following this procedure, it required the picking of 25 to 50 individual clones to
identify a positive plasmid, no matter if one or two enzymes were used for the
digestion of the BAC clones. The number of clones I had to analyze by PCR
amplification to obtain the targeted DNA was lower than expected, if one assumes
that all fragments generated by the restriction digests are equally likely to be inserted
into the vector. There may be a bias for insertion of fragments of 1kb and larger,
however, I did not test this further. In 2 out of 24 experiments, even extensive
screening of more than 300 colonies yielded no result, however, a repetition
employing different restriction enzymes was in both cases successful. It is likely that
the sequence information was inaccurate, but other reason cannot be excluded. In
total, 17 fragments of six different genes were isolated following this technique.
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Figure 4.5: Examples of isolated mouse genomic DNA fragments
The table contains the gene names, the identifier for each TIGR BAC clone, the restrictions enzymes
which were used for the digests, the number of fragments produced by each digestion (#), the exact
numeric position of the isolated fragment in the BAC clone, their sizes in kilobases the primers used
for the PCR reactions together with the T7 or T3 primers. En1 = engrailed-1 Foxa1 = fork head box A1
transcription factor DDC = deleted in colorectal carcinoma DRD2 = dopamine receptor 2 Pbx1 = pre-
B-cell leukemia transcription factor 1 pBs = Bluescript II SK (-). T3 primer sequence:
GTAATACGACTCACTATAGGGC, T7 primer sequence: AATTAACCCTCACTAAAGGG (Scholz
et al., 2006)
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4.2.2 Designing and cloning the Foxa1 targeting vector
Applying the technique described in the previous section, I used restriction digest
fragments of BAC clones RPCI-23-91E17, AZ244633 and AZ246635 to design a
targeting construct which included the entire coding sequence of exon 2 and
approximately 7.5 kb of flanking intronic sequence cloned into a modified pFLRT
vector (kindly provided by Prof. Rüdiger Klein, Munich). The multiple cloning site in
this pFLRT.m2 vector contain additional unique restriction sites. The positive
selection marker PGKneo was flanked by two Flipase Recognition Target (FRT)
recombination sites.
Figure 4.6: The
Foxa1 loxP
knock-in
construct.
Exon 2 of the
Foxa1 gene is
flanked by two
loxP sites. The
Neo sequence is
flanked by two
F L R T  s i t e s
m a k i n g  a
removal of Neo
p o s s i b l e ,  i f
necessary. 4.2 kb
of 5´ and 7 kb of
3 ´  f l a n k i n g
sequence
complete the
construct. The
total size is 14.3
kb.
In a process analogous to the one used in the CRE/loxP system, the PGKneo sequence
could have been removed by crossing the FRT carrying mice with a strain universally
expressing recombination enzyme (FLP or Flp). This strategy is similar to the one
described by (Long et al., 2003) where a mammary gland specific deletion of both
ErbB4 alleles was generated. A low-passage aliquot of TBV-2 embryonic stem cells
(generously provided by Prof. Wolfgang Wurst, Munich) was then grown on MitoC
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growth inhibited fibroblasts and maintained in an undifferentiated state by the
addition of LIF (leukaemia inhibitory factor). The first electroporation of 22.5x106
cells with a NotI linearized Foxa1 loxP construct yielded close to 100 colonies after
10 days of G418 (neomycin) selection, out of which 60 were picked based on their
apparently undifferentiated state and size. They were analyzed via Southern blot to
detect cells in which the construct had replaced the wild type sequence.
Figure 4.7:
Generation of Foxa1
loxP knock-in mice.
(a) BAC restriction
digest fragments
used for designing
the targeting vector.
Three BACs were
d i g e s t e d  a n d
s c r e e n e d  f o r .
Together, the three
genomic fragments
cover exon 2 of the
Foxa1 alpha gene as
well as 4.2 kb of 5´
and 7  kb of
3´flanking sequence.
(b) Structure of the
mouse Foxa1 locus.
The Foxa1 loxP
knock-in targeting
vector is shown
below.
Abbreviations: A,
AscI; B, XbaI; C,
ClaI; E, EagI; H,
HindIII; X, XhoI;
neo, PGKneo G418
resistance cassette used for positive selection flanked by FRT recombination sites (shaded triangles).
Black triangles, loxP recombination sites flanking exon 2. (c) Radioactive Southern blots of XbaI
digested genomic DNA from Tbv-2 ES cells that have undergone recombination. An 3´external probe
was used to screen for correctly targeted integration by Southern Blotting. The wild-type allele of
Foxa1 generates a band with the predicted size of 12.4 kb with this probe, whereas the mutated allele
gives a band of 8.9 kb. The 12.4 kb wild-type band is present in both samples. A 8.9 kb band is present
in the left sample, showing a correctly targeted Foxa1 alpha locus.
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Figure 4.8: Timeline for the ES cell culture and Foxa1 loxP electroporation
ES cells were maintained in an undifferentiated state by the addition of LIF to the medium.
Electroporated ES cells were given 24 hours time before begin neomycin selection. After selection,
colonies were picked according to their undifferentiated state and appropriate size.
Radioactive Southern blots were performed on XbaI digested genomic DNA obtained
from the colonies. A 3´ external probe was used to screen for correctly targeted
integration. The wild-type allele of Foxa1 generates a band with the predicted size of
12.4 kb with this probe, whereas the mutated allele gives a band of 8.9 kb.
Out of 60 colonies picked, 5 colonies showed a correctly positioned insert on one arm
of the sequence, however, blots with probes against the 5’ arm were all negative.
After reducing the probes size and using different parts of the probe sequence, I came
to the conclusion that the construct, while correctly inserted, had an unknown
sequence next to it. Although I repeated the experiment and picked another number of
colonies, I could not analyze and proceed with the project, and shifted my focus on
the research of the KATP channels and their function under oxidative stress.
Figure 4.9: Summary of ES clones
analyzed
Of about 100 ES cell colonies present
after neomycin selection, 40 colonies
contained or consisted of differentiated
cell. These were not picked.
ES colonies after electroporation ca. 100
ES cell colonies picked 60
Positive 3’ Southern blot 5
Positive 5’ Southern blot 0
Day 0: plating of MitoC treated feeder cells (fibroblasts)
Day 1: plated 2.5x106 TBV-2 ES cells on 6 cm MitoC feeder plate
Day 2: grew to confluency
Day 3: split 1:6 on 9 cm MitoC feeder plates
Day 4 and 5: grew to confluency
Day 6: pooled 3 plates for electroporation, pooled 3 plates for later use, 22.5x106
cells were used for electroporation
Day 7: begin of neomycin selection of ES cells
Day 10: cells without recombinant DNA begin to die
Day 16: picking of ES cell clones of appropiate size and shape into 96 well plates
for storage and 24 well plates for growing and use for genomic Southern
blots
Day 20+: isolation of genomic DNA, begin of Southern blots
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4.3 ChIP assay to verify binding of Pbx protein to AADC promoter
The TALE class transcription factor Pbx1a has long been implicated in altering
engrailed protein function in the midbrain (Gemel et al., 1999). In an in-silico
promotor study performed in our lab, a putative binding site of Pbx1a on the promotor
of the l-aromatic amino acid decarboxylase (AADC) gene was found (unpublished
results).
AADC is part of the biosynthesis chain of dopaminergic neurons and converts L-
dihydroxyphenylalanine to dopamine. It is regulated by Nurr1 (Hermanson et al.,
2003; Smits et al., 2003).
To verify in vitro binding of Pbx1a to the AADC promoter, I performed a chromatin
immunoprecipitation assay (ChIP assay) on DNA/protein harvested from cells of the
murine neuroblastoma cell line N2A. To assure Pbx is expressed, we used a
transfected N2A clone which expresses both engrailed and Pbx1a under the control of
the TetON system (Gossen and Bujard, 1992). The TetOn system comprises a
plasmid which expresses a tetracycline-controlled transactivator which in turn is able
to drive the expression of a target gene in the plasmid in the presence of an effector,
doxycycline.
To compensate for low DNA concentrations which may arise from low cell numbers,
two nested primer pairs were designed (see Materials and Methods). The specifity of
the primers was tested on mouse genomic DNA. 1 µl of a 50 µg/ml sample was used
in PCRs with an annealing temperature ranging from 58 to 64°C. Both primer pairs
produced a product of expected length at every temperature, although at 64°C it was
weaker. Therefore and to guarantee optimal annealing, the annealing temperature was
set to 57°C in all following PCRs.
N2A cultures were incubated with 5 mg/ml doxycycline (D9891, Sigma-Aldrich,
Germany) for 24 hours, after which +dox culture and –dox control were harvested and
processed according to manufacturers instructions (Cat.No.: 17-295, Upstate, USA).
In brief, cells are fixed and lysed, then the DNA (with bound proteins) is sonically
shreddered and incubated with an anti-Pbx antibody (sc888, SantaCruz, USA) bound
to an agarose matrix. Bound DNA-protein-antibody-matrix is collected and the DNA
is purified. The histones were removed via a high-salt/high-temperature step. Before
and after sonification, samples were set aside to test for presence of AADC sequence
via PCR, to be able to see whether the sequence was still contained in the solution. 2
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and 4 µl of each step, including the final eluation, were used in a PCR with the two
outer primers. 2 µl of these first two reactions were then used in a PCR with the two
inner primers, producing four product lanes per product set aside.
In both –Dox and +Dox samples, the AADC sequence could be amplified from all
samples at the expected size of 209 bp, but not from the eluate, suggesting that Pbx1a
does not bind to the AADC promotor under these conditions. However, lacking an
appropriate positive control, a failure of the assay itself can not be excluded. The use
of the Pbx-overexpressing N2A cell line might also be problematic as it could
theoretically produce secondary effects of protein aggregation and steric blocking or
might contain methylated and therefore unresponsive DNA sequences.
Figure 4.10: Gel of PCR after ChIP assay
Before and after sonification samples of the solution were set aside and run in a PCR with outer and
inner AADC primers. DNA not bound to the column was used as well. In both –Dox and +Dox
samples, the AADC sequence could be amplified from all samples at the expected size of 209 bp, but
not from the eluate, suggesting that Pbx1a does not bind to the AADC promotor under these
conditions.
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4.4 Lmx1b heterozygous phenotype of aged animals
Ever since the LIM homeobox transcription factor Lmx1b had been implicated to be
important for mesDA development (Burbach et al., 2003), a role for this factor as a
survial factor could not be excluded. As homozygous mutant mice die within 24 hours
after birth (Chen et al., 1998), I therefore investigated aged animals heterozygous for
Lmx1b (-/+) for a loss of TH+ neurons in the ventral midbrain. Animals of about 22
months of age were sacrificed, the brains were isolated, cut as floating sections and
stained with an anti-TH antibody (as described in the Materials and Methods section
of this work). On a gross morphological level, no differences in the amount of the
cells in the SNpc and VTA or the density of axons in the striatum could be seen. This
suggests that unlike the engrailed haploid insufficiency, a reduced expression of
Lmx1b does not lead to a loss of mesDA neurons in mice. Since I was not interested
in a possible slight change in cell numbers, they overall mesDA cell number of the
mice was not determined.
Figure 4.11:
Lmx1b -/+
mice have a
normal
mesDA system
Lmx1b+/-
mutant mice
exhibit a
normal
number and
distribution of
DA neurons in
the SNpc and
VTA. Below
as comparison
the reduced
SNpc of a
EnHT mouse
and normal
SNpc of a wild
type mouse.
Scale bar is
1mm, dorsal is
up
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5 Discussion
The nigral dopaminergic neurons exhibit a specific vulnerability to cellular stressors,
which becomes apparent in the degeneration of these neurons in Parkinson’s Disease.
The Fox genes are expressed by mesDA neurons and regulate the expression of KATP
channels in this neuronal population. Given their well-known role as regulatory
elements in cellular stress and energy metabolism, they are likely candidates for
having an influence on mesDA cell death. Study of their effect under defined
conditions of mesDA challenge may provide insights into the molecular mechanism
of the nigral cell death.
In this work, I present evidence for a negative effect of KATP channel activation on
mesDA neurons under oxidative stress. On E12 mouse primary cultures of ventral
mesencephalon, the opening of KATP channels via pinacidil increased the rate of
mesDA cell death under oxidative stress, no matter if 6OHDA, MPTP or rotenone
was used. Conversely, a forced blocking of the KATP channels by tolbutamide or by an
unspecific potassium channel blocker, tetraethylammonium, is leading to an increased
rate of cellular mesDA survival.
Furthermore, the differential effect the drugs have on the cultures treated with the
three toxins provides evidence that distinct molecular mechanisms of inducing cell
death are activated by each toxin, even if all induce apoptosis.
An in vivo model of gradual mesDA loss, the EnHT mouse, provided me with a
markedly different type of environment. Here, I demonstrate that inactivation of the
KATP channel by crossing EnHT mice with the KATP channel defective SUR1 mutant
rescues the progressive mesDA cell loss occurring in these animals.
Taken together, the data provided in this work highlights the importance of KATP
channel function in mesDA neuron stress and further understanding of the specific
vulnerability of this cell population to stressors. This mechanism might help in the
development of treatments against the neuronal degeneration occurring in Parkinson’s
Disease.
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5.1 KATP channel function in cellular stress
5.1.1 pmKATP activation in hypoxia and ischemia
In the work I present here, blocking of KATP channels of the dopaminergic neurons of
the ventral midbrain, leads to a partial rescue when these cells are under oxidative
stress caused by MPTP or rotenone. This mechanism seems not to be present in other
cell types or might depend on the circumstance of the challenge.
There, activation of KATP channels on the plasma membrane (pm KATP) at low ATP
levels is known to lead to a hyperpolarization and consequently to a reduced
frequency of action potentials, which are very energy consuming (Nichols, 2006). In
short, the cell saves energy by becoming more unresponsive. Intuitively, one might
think that opening of pmKATP channels has therefore a positive effect on cell survival,
especially in a situation where the cellular energy supply is impaired, as is the case in
ischemia or hypoxia.
Indeed, after hypoxia in cardiac myocytes has taken place, ATP levels drop and the
opening of pmKATP channels on the cell shortens the its action potentials (Nichols et
al., 1991). KATP channel opening in vascular smooth muscle cells in reaction to
oxygen shortage leads to vasodilatation (Quayle et al., 1997). Both mechanisms show
a compensation of the open KATP channel in reaction to energy demand. The cardiac
cell saves energy through less work, the blood vessel dilates to enhance the rate
energy and oxygen can be supplied to muscle tissue. This has been used to strengthen
cells against a strong ischemic insult. A short withdrawal of oxygen followed by
reperfusion leads to an improved cell survival rate after a subsequent long ischemic
pulse (Gok et al., 2006). Pharmaceutically, this ischemic preconditioning (IPC) can be
triggered by KATP channel openers (KCOs) like pinacidil and others.
5.1.2 m KATP channels in hypoxia and ischemia
Similarly, KATP channels on the inner membrane of the mitochondria are known to
affect cellular survival by opening under conditions of cellular energy shortage. The
mechanism of this effect is still a matter of discussion. When the mitochondrial
membrane potential is collapsing due to outside influence like oxygen deprivation or
toxins, the potassium diffusion into the matrix will be inhibited, causing the
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mitochondrion to contract (Garlid and Paucek, 2003). There is evidence that mKATP
channels may buffer changes in matrix volume and inter-membrane space, as well as
modulating the accumulation of free calcium, which would help to overcome
mitochondrial stress (Rousou et al., 2004).
To my best knowledge, there are only two publications, by Tai and colleagues (Tai
and Truong, 2002) (Tai et al., 2003), who investigated m KATP channel function in a
toxin assay similar to what is shown in this work.
This group demonstrated a positive effect of mitochondrial KATP openers on rotenone
treated undifferentiated PC12 cells. In order to separate a possible mitochondrial KATP
(mKATP) channel contribution and a plasma membrane one (pmKATP), Tai et al. used
patch clamping and various KATP openers and blockers and found that pmKATP
channel activity is not detectable under any of the conditions tested. This means that
the positive effect of the KATP channel openers had to come from an activation of
mKATP channels. However, Tai et al. used undifferentiated cells of the PC12 cell line
for their experiments, which was isolated from rat pheochromocytoma of the adrenal
medulla. Therefore, these cells are likely not similar to mesDA neurons in their
molecular makeup and if their reaction KATP channel mirrors something occurring in
mesDA neurons is questionable.
There is also evidence that activation of mKATP channels alone may lead to a) a
decrease of membrane potential by increasing the permeability of the mitochondrial
membrane, b) mitochondrial swelling which will hinder ATP synthesis and finally, c)
to a release of cytochrome c (Scatena et al., 2007). Therefore, the effect of mKATP
activation most likely depends on if the mitochondria are already challenged by e.g
energy depletion or ROS, or not.
Research on mKATP channels is hindered by the fact that the subunits of the mKATP
have yet to be identified. It is assumed but as of now unproven that the mKATP
channels have the same or at least very similar subunit composition as the pmKATP
channels. There is evidence for other Sur-like proteins, some of which are much
smaller than the known isoforms (Szewczyk et al., 1997). It has been speculated that
this size-reduction might reflect an adaptation to the more limited space on
mitochondrial membranes. An interesting finding has the been the identification of
functional mKATP channels in myocytes of Kir6.1 and 6.2 mutant mice (Miki et al.,
2002) (Suzuki et al., 2002), which do not express any KATP  channel on the plasma
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membrane. This shows that other proteins aside from Kir6.1 and 6.2 are present and
able to form a mKATP channel. Whether they are compensating for a lack of Kir6.x or
representing actual wild-type mKATP channel subtypes is unknown.
Figure 5.1: Physiological and pharmacological agents which affect mKATP channels
It is assumed but as of yet unclear if mKATP channels consist of similar subunits as pmKATP channels.
Other factors, aside from the ones shown in the figure, such as reactive oxygen species or protein
kinase C, can also affect function of the mKATP channel.
(Kir, inwardly rectifying potassium channel subunit; SUR, sulfonylurea receptor subunit; 5-HD, 5-
hydroxydecanoate; Resp. Chain, Respiratory Chain; ATP, adenosine triphosphate; ADP, adenosine
diphosphate) (Busija et al., 2004).
In summary, it is likely that both m and pmKATP channels are activated during
oxidative stress, but the available information on mKATP structure and indeed,
function, is scarce. Tolbutamide and pinacidil bind to and activate both m and pm
KATP channels. Experimentally, one would need m or pm KATP specific blockers and
openers to separate their function, e.g. the mKATP specific activator diazoxide and the
blocker 5-hydroxydecanoate. It remains to be seen what the effect of these substances
on mesDA neurons is. Moreover, taken into account the relative short time frame in
which hypoxia and ischemia are experimentally studied (usually under 24 hours) and
the long time period PD models need to cause neurodegeneration (24 hours to
months), it is possible that an initially beneficial effect like the activation of KATP
channels in hypoxia, turns into something causing additional stress and cell death
after a certain time point, as can be seen in the presented results.
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5.1.3 KATP blocking and neurodegeneration
There is some more evidence for KATP channel blocking as a protective measure
against oxidative stress in mesDA neurons. Liss and colleagues applied MPTP and
rotenone to patch-clamped mesDA neurons and discovered that the neurons are
completely electrically silenced under these conditions. When tolbutamide was added
to the solution, the normal firing pattern of the cell was restored (Liss et al., 2001)
(Liss et al., 2005). When they injected MPTP and into Kir6.2 deficient mice, which
lack a pmKATP channel, they discovered that the mesDA neurons were significantly
more resistant to the effect of MPTP than wild type mice (Liss et al., 2005 368).
Evidence for a positive effect of pmKATP blocking also comes from experiments done
in the lab of Gang Hu and others. Ironically, this group investigated the effect of a
novel KATP channel opener, iptakalim, on rat midbrain slice cultures and detected a
protective effect of iptakalim in the haloperidol model of PD which also targets the
respiratory chain in the mitochondria (Wang et al., 2005) (Yang et al., 2005). Since
none of their experiments provided direct evidence that iptakalim actually opened
KATP channels, eventually mesDA neurons were patch-clamped and an increase in
spontaneous firing was detected upon addition of iptakalim, which was mirrored by
the application of the blocker tolbutamide. Iptakalim turned out to be a rather specific
pmKATP channel blocker, not opener (Wu et al., 2006).
Similarly, the data presented here shows that this positive effect is present in primary
cultures treated with rotenone and either tolbutamide and TEA, and MPTP where
there cell survial is mediated by TEA only. Consequently I propose the following
mechanism for KATP function in oxidative stress on mesDA neurons.
5.1.4 Hypothesis of KATP function in mesDA oxidative damage
One of the tasks of KATP channels is to tie the excitability of a cell to the state of its
energy supply. Dropping ATP to ADP levels lead to an activation of pmKATP and
mKATP channels. Consequently, in a normal in vivo situation with sufficient glucose
supply, both pmKATP and mKATP channels are closed (Garlid and Paucek, 2003;
Nichols, 2006).
Insult with either 6OHDA, MPTP or rotenone will lead to the generation of large
amounts of ROS via inhibition of the electron transport chain of complex I in
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mitochondria, which is one predominant feature that is shared between the three
toxins. MPTP and rotenone affect even the same protein, the NADH-ubiquinone
reductase, while 6OHDA may generate ROS through a variety of mechanisms
(Schober, 2004) (Testa et al., 2005).
5.1.4.1 Effect of pmKATP channels
The inhibition of mitochondrial ATP production leads to the activation of the pmKATP
channels (Liss et al., 2005). The open pmKATP channel then hyperpolarizes the cell by
leading to an efflux of potassium ions from the cell against the electrical gradient but
following the concentration gradient. This hyper-polarization is electrophysiologically
silencing the cell. Disregarding the possible parallel effect of mKATP channels, a lack
of neuronal excitability alone can promote cell death in immature mesDA neurons of
the rat (Salthun-Lassalle et al., 2004). If this is also the case for mature neurons is,
however, unknown.
5.1.4.2 Effect of mKATP channels
As both ROS and low ATP levels are known to activate mKATP channels and they in
turn lead to the production of ROS, a toxin such as MPTP will lead to a massive
generation of reactive oxygen species, causing damage to proteins, forming of the
mitochondrial transition pore (MTP), efflux of cytochrome c into the cytosol and
finally apoptosis (Kukreja, 2006). As stated earlier, the effect of the mKATP channel in
regards to having a protective effect is most likely dependent on the state of the cell
and the strength of the insult to the mitochondria. Given that most ischemic insults are
transient and are causing primarily a depletion of ATP and only as secondary effect
the production of ROS, I propose that the direct binding to and inactivation of
complex I proteins such as NADH-ubiquinone reductase confers damage to the
mitochondria on a scale the activation of mKATP channels is not able to buffer. Even
more, the activation and following additional production of ROS might very well add
to the already high level of ROS present caused by inhibiting complex I and enhance
cell death as seen with the pinacidil treatment. In this mechanism, time might also be
a factor, in the sense that a certain threshold of ROS has to be reached before cell
death is triggered.
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5.1.5 Differential effect of drugs and toxins
While the toxins used in this work are known to target complex I of the mitochondrial
respiratory chain, each has additional mechanisms to cause cellular stress and
apoptosis. Rotenone is known to inhibit microtubule formation and there is evidence
that monomeric tubulin causes cell death (Brinkley et al., 1974; Marshall and Himes,
1978). MPTP can inhibit complex III and IV of the respiratory chain as well as
interacting with a number of cyotosolic proteins (Mizuno et al., 1988). Finally,
6OHDA has a wide range of possible ways to cause cell death. Once in the cell, 6-
OHDA can undergo spontaneous non-enzymatic auto-oxidation to give rise to
secondary toxins, such as quinones (Saner and Thoenen, 1971) and superoxide
radicals, in addition to hydrogen peroxide. In the presence of iron II, 6-OHDA can
also produce harmful hydroxyl radicals via the Fenton reaction (Cohen and Heikkila,
1974). Taken together the various mechanisms by which each used toxin can induce
cell death, it is not surprising that the three used drugs have similar different effects
on cellular survival.
Tolbutamide and pinacidil both bind to and block/activate pmKATP as well as mKATP
channels. In that light it is interesting that both drugs have little or no effect on MPTP
treated cells, but a rather distinct effect on cells which were treated with rotenone. As
said before both toxins have additional secondary mechanism of triggering cell death,
furthermore there is evidence that the intra-cellular apoptosis pathway of between
these two is different as well (Choi et al., 1999).
5.1.6 TEA: different mode of apoptosis?
The strong effect TEA has on rotenone and MPTP treated primary cultures might be
evidence for other nolecular mechanisms of apoptosis. TEA blocks almost every type
of potassium channel on the plasma membrane, but does not enter the cell and
therefore is unable to block mKATP channels (Garlid and Paucek, 2003). While it
cannot be excluded that TEA binds more strongly to pmKATP channels or is more
resistant to degradation than tolbutamide, the available literature suggests another
possibility. Several ischemic insults on cortical and CA1 hippocampal neurons cause
an NMDA receptor-mediated excessive K+ efflux from the cells and subsequently a
depletion of intracellular potassium. This is thought to trigger apoptosis and can be
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partially alleviated by the addition of TEA in vitro (Yu et al., 1997) (Wei et al.,
2003).
Another more PD-related example of involvement of other types of potassium
channels comes again from the work of Liss et al. who investigated the molecular
mechanism of mesDA cell death in the weaver mouse. In this naturally occurring
mutation of the inwardly rectifiying potassium channel Girk2, the channels lose their
ion-specifity and allow a non-selective cation influx which causes cell death (Liss et
al., 1999b). In the same work, evidence is presented that the ion influx activates KATP
channels. Interestingly, after crossing the weaver mouse with Kir6.2 mutant mice,
which do not express a KATP channel on the plasma membrane, only a weak rescue of
the weaver phenotype was be observed, again pointing to a different pathway of
apoptosis (Liss et al., 2005). Taken together, the effect of TEA on the toxin assays
likely represents involvement of several potassium channel-related mechanisms
triggering cell death. Whether this is representing an artefact connected to the
additional effects the toxin have on cells or mirrors a PD-like in vivo situation, is
unclear.
5.1.7 Towards specifity: cellular differences between VTA and SNpc
The presence of KATP channels alone does not explain why DA neurons from the
SNpc subpopulation in the ventral mesencephalon are more vulnerable to insults than
the neighbouring DA neurons from the VTA. As stated earlier, the molecular make up
of mKATP in general is unclear, and most likely contains additional as of yet
unidentified sub-units of at least the SUR family (Miki et al., 2002) (Suzuki et al.,
2002). The expression of pmKATP channels, however, has been studied extensively. In
over 95%, the mesDA neurons of both SNpc and VTA express the same type of
channel, built from Kir6.2 and Sur1 (Liss et al., 2005). Therefore, the presence of this
channel alone is not explaining the differential vulnerability of the SNpc neurons to
cellular stressors. One difference between the two populations are the different
expression levels of the uncoupling protein 2 (UCP-2) (Andrews et al., 2005). As
mild uncoupling is known to reduce the amount of reactive oxygen species (ROS)
(Krauss et al., 2005), it was speculated that a higher level of uncoupling in the VTA
might make these cells more resistant to oxidative stress. Lack of UCP-2 was shown
to sensitize mesDA neurons against MPTP insult, whereas a two-fold over-expression
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of the protein reduced the number of dying cells by 30%, using the same experimental
setup (Andrews et al., 2005). Subsequently, a three-fold higher expression of the
neuronal uncoupling protein UCP-2 in the VTA was found (Liss et al., 2005),
although this was not confirmed by a genetic screen (Chung et al., 2005). Additional
artificial uncoupling of the mesDA neurons made the SNpc neurons more resistant to
complex I inhibition. The VTA became more sensitive to inhibition of complex I, the
pmKATP channels were activated and the cells ceased their spontaneous firing (Liss et
al., 2005). As proposed earlier, this could be interpreted in a way that mitochondrial
uncoupling up to certain degree protects against oxidative stress, as can be seen in the
normal higher expression of UCP-2 in the VTA and the artificially level of
uncoupling in the SNpc under experimental conditions. Is the level of uncoupling too
high, the cells is put under more stress and reacts by opening the pmKATP channels. To
further study this mechanism, it would be interesting to compare the expression levels
of other neuronal populations which are affected in PD, like e.g. the neurons in locus
coeruleus, raphe nuclei or olfactory bulb.
5.1.8 Involvement of the engrailed genes in oxidative stress
The effect of the Sur1 mutation on EnHT mutants suggests a convergence of engrailed
and KATP function. The lack of engrailed leads to an increasingly drastic loss of
mesDA neurons depending on the number of engrailed 1 and engrailed 2 alleles
which are missing (Sgado et al., 2006). MesDA cells dying in these mutants enter
apoptosis via the caspase-dependent mitochondrial pathway. Caspases 3 and 9 are
activated, there is an increase of cytosolic cytochrome C, most likely because of an
opening of the mitochondrial transition pore (MTP) and subsequently, cell death.
Primary cultures of double mutant E12 embryos were shown to be more sensitive to
rotenone treatment than littermates carrying only the En2-/- mutation. Conversely,
N2A cells over-expressing engrailed were more resistant to MPTP treatment than
wild type cells (Alavian, submitted). Therefore, the role of engrailed seems to
converge with KATP channel function on the level of the formation of the MTP when
the cell is under stress. Insofar, it is conceivable that a lack of KATP channel function
has a protective effect on the progressive loss in EnHT mice. However, more animals
carrying both Sur1 and EnHT mutation need to be analysed. Given that EnHT mice lose
their SNpc neurons over a fixed period of time, it also would be interesting to
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compare Sur1-/+EnHT animals to EnHT, to see whether the deletion of a single allele is
able to slow the degeneration of the DA neurons.
Figure 5.2: Role of engrailed in oxidative stress and apoptosis
Loss of engrailed expression leads to instability of mitochondrial membrane, and increased sensitivity
to mitochondrial damage by (for example) MPTP (Alavian, submitted).
5.2 Requirement of engrailed for DRN and LC
Mutant mice deficient for both engrailed genes show a specific loss of the DRN and
LC, whereas two adjacent nuclei, the MRN and NSC, which belong to the same pool
of neurotransmitter-specific neurons, are not affected. Our study and the data I present
here, comprises the first report that these nuclei require different positional
information for their development. Other transcription factors like Otx2 and Gbx2
define the neuroepithelium rostral or caudal to the isthmus, respectively, but do not
have such a distinct function for these neurons. The finding that En1 mutant mice
develop almost normally in respect to DRN and LC, indicates that the En1 and En2
genes are largely functionally redundant in respect to the development of ventral
mid/hindbrain.
The expression of Lmx1b and Pet1 in the 5-HT precursor cells and the post-mitotic
neurons (Hendricks et al., 1999) (Ding et al., 2003) suggests a cell-autonomous
requirement, as the neurons fail to differentiate and are absent in the respective
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mutant mice. However, the loss of DRN in the engrailed mutants, the lack of
engrailed expression in the post-mitotic neurons, suggests that En1 and En2 provide
positional information in the neuroepithelium acting prior to Lmx1b and Pet1.
The location of NSC noradrenergic neurons just directly ventral to the LC, its
scattered distribution and an afferent projection which is often indistinguishable from
the LC led occasionally to the conclusion that the noradrenergic neurons of the NSC
are just a low density extension of the LC and not a distinctive population of neurons.
Our finding that the NSC is not affected in En1/2 double mutants suggests that LC
and NSC are of different ontogenetic origin and are therefore two separate cell
populations in the same way as serotonergic neurons of the MRN and DRN. The
physical vicinity of LC and NSC is either a mere coincidence or reflects the fact that
they both require Fgf8 for their induction (Ye et al., 1998).
5.3 One step cloning – a fast way to obtain DNA fragments of defined size
Recently, the nucleotide sequences of entire genomes became available. This
information combined with older sequencing data discloses the exact chromosomal
location of millions of nucleotide markers stored in the databases at NCBI, EMBO or
DDBJ. Despite having resolved the intron/exon structures of all described genes
within these genomes, the sequencing data opens up other interesting possibilities.
The isolation of smaller genomic fragments from larger genomic clones like BACs
(bacterial artificial chromosomes) or others is usually a time consuming process and
requires a significant amount of resources. It normally involves screening of libraries
either by PCR or hybridization (Campbell and Choy, 2002) followed by a
fragmentation process and re-screening until a plasmid is isolated containing the
targeted DNA.
I could demonstrate that combining genome and BES (BAC end sequence) data
substantially reduces the time necessary to isolate defined genomic fragments from
BAC clones of species with a fully sequenced genome. The method reduces the
process to a single cloning step requiring only common reagents and equipment.
Using standard restriction enzymes, I cloned specific DNA fragments of 1 to 10 kb in
Discussion
98
size from a given BAC in less than 48 hours. This method should be applicable to
similar sources of subcloned genomic DNA like PACs (Sternberg, 1992), YACs
(Burke et al., 1987) and others, if sequences of the ends as well as of the underlying
genome are known as in the cases of the here described BACs. The used Bluescript
vector can be substituted for any vector with a comparable number of specific
restriction sites within its multiple cloning site. This method works with very high
fidelity compared to another widely used alternative procedure, long-range PCR,
which is notoriously unreliable, even on low-complexity templates, e.g. BAC clones.
The strategy presented here may become the method of choice to isolate defined
genomic DNA out of larger genomic clones.
5.4 Future perspectives
There is little data available today on KATP channel function in regard to PD. Groups
working on stroke usually operate in a time-frames of a few hours for their
experiments and not over the course of 24 hours or even longer as it is necessary to
emulate a progressive loss like seen in Parkinson’s Disease. Depending on their
respective model system, the KATP channels have different sub-unit compositions, and
the sub-units of the mKATP channels have yet to be identified in a definitive way.
Even when focusing on a certain type of cell and condition, most groups looking to
manipulate KATP channel state have used substances which exert their effect on both
mKATP and pmKATP channels, if the effect on mKATP channels is considered at all.
In this work, I used the KATP channel blocker tolbutamide and the opener pinacidil on
E12 primary cultures. Both drugs affect pmKATP and mKATP channels and the positive
effect of tolbutamide and negative effect of pinacidil on mesDA survival needs to be
studied in more detail.
Therefore, it is advised to built upon the existing data on KATP function in PD models
with agents specific for m and pmKATP channels, respectively. As noted, e.g.
iptakalim was identified as a specific pmKATP blocker, whereas BMS 191095 or
diazoxide activate solely mKATP channels.
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Furthermore, it would be interesting to compare the effect of these drugs to the ones
used here and in other chemical and animal models of nigral degeneration, like the
haloperidol model mentioned above and the e.g. the aphakia mouse/Pitx3 mutant.
This especially goes for the unspecific potassium channel blocker TEA, since my
work points to the possible involvement of additional non-KATP potassium channels in
other molecular mechanisms of apoptosis.
The rescue of the EnHT phenotype by the addition of the homozygous Sur1 mutant
points to a convergence of the pathway by which engrailed is influencing mesDA
survival and the action of the KATP channels. More animals need to be studied to
define this connection further, possibly by the additional investigation of dopamine
levels in the striatum and an electrophysiological comparison of EnHT and Sur1EnHT
mice.
The literature data on UCP2 levels and its effect on ROS levels is one possible
explanation for the differential vulnerability of the nigral neurons. However, it is
inconclusive as long as it is not clear whether other neuronal populations affected by
PD have similar level of UCP2 expression as the DA neurons of the SNpc.
Taken together, the data presented here further cements the role of KATP channels in
oxidative stress and cell death and may provide new insight for the development of
drugs for treatment of Parkinson’s Disease.
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6 Abbreviations
AADC l-Aromatic amino acid decarboxylase
Aldhd2 Aldehyde dehydrogenase 2
AP Anterior-posterior
ATP Adenosine Triphosphate
AVE Anterior visceral endoderm
BDNF Brain-derived neurotrophic factor
BMP Bone morphogen protein
bp base pairs
cDNA Complementary deoxyribonucleic acid
CNS Central nervous system
DA Dopamine
DAT Dopamine transporter
DNA Deoxyribonucleic acid
DMEM Dulbecco modified eagle medium
dNTP Desoxyribonucleotide
dpc Days post coitum
DV Dorsal-ventral
E Embryonic day
EDTA Ethylene diamine tetracetic acid
En Engrailed
EnHT En1+/-;En2-/-
En1 Engrailed-1
En2 Engrailed-2
Fgf Fibroblast growth factor
FCS Fetal calf serum
Foxa1 Forkhead containing transcription factor I (formerly HNF3α)
FP Floor plate
Gbx Gastrulation brain homeobox gene
GDNF Glial cell line derived factor
Kir6.2 Rectifying potassium channel element
LB (medium) lysogeny broth
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L-DOPA L-3,4-dihydroxyphenylalanine (also called Levodopa)
Lmx LIM homeodomain-containing transcription factor
MAO Monoamine oxidase
MHB Mid-hindbrain boundary
mKATP Mitochondrial KATP channel
MPT Mitochondrial permeability transition
MPP+ 1-methyl-4-phenylpyridinium
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
6-OHDA 6-hydroxydopamine
Otx Orthodenticle homologue
Park-1 Parkin-1
Park-2 Parkin-2
Pax Paired box genes
PC12 Rat pheochromocytoma cell line
PCR Polymerase chain reaction
PBS Phosphate buffer saline
PD Parkinson’s disease
PFA Paraformaldehyde
Pitx3 Paired-like homeodomain transcription factor
pmKATP Plasma membrane KATP channel
RNA Ribonucleic acid
ROS Reactive oxygen species
RRF Retrorubral field
RT Reverse transcriptase or room temperature
Shh Sonic Hedgehog
SN Substantia nigra
SNpc Substantia nigra pars compacta
Sur1 Sulfonyl receptor I
Tgfβ Transforming growth factor beta
TH Tyrosine hydroxylase
TGF Transforming growth factor
TLZ tauLacZ
µCi micro Curie
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µF micro Farad
V volt
VE water de-mineralized (“vollentsalztes”) water
VMAT Vesicular monoamine transporter
VTA Ventral tegmental area
Wnt Wingless homologue transcription facto
Index
103
7 Index
6-OHDA, 47, 59, 98, 107, 127
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aphakia mutant, 25, 105
apoptosis, 35, 65, 68, 92, 97, 98, 99, 101, 102,
105, 110, 111, 115, 117, 130, 133
ATP, 35, 36, 38, 39, 93, 94, 95, 97, 106, 114,
116, 117, 127
AVE, 15, 16, 106
axon, 30, 89, 122, 126
Bdnf, 106
bone morphogenetic protein (BMP), 106
bradykinesia, 12, 29
caudate putamen
dorsal striatum, 28
striatal, 30
cell death, VI, 14, 26, 33, 34, 39, 42, 59, 60,
61, 62, 63, 64, 65, 72, 74, 92, 96, 97, 98,
99, 101, 105, 114, 129, 130
cell-autonomous, VI, 13, 24, 40, 102, 111
cerebellum, 17, 18, 20, 21, 44, 114, 121, 127,
131
chimera, 23
DAT, 23, 26, 35, 36, 106
differential display, 13, 40, 41, 80, 110
differentiation, 20, 22, 25, 26, 121, 127, 132
dopamine, 12, 13, 22, 25, 26, 29, 35, 36, 39,
42, 58, 59, 68, 69, 70, 71, 74, 75, 80, 83,
87, 89, 100, 101, 105, 106, 110, 111, 112,
113, 116, 118, 119, 120, 122, 125, 126,
128, 129, 131, 132, 133
dopamine receptor 2, 83
drosophila, 16, 18, 20, 32, 77
embryonic stem cells, 27, 52, 58, 85, 86, 110,
122, 126
En1-/-, 13, 21, 76
En2-/-, VI, VIII, 13, 21, 24, 25, 40, 44, 101,
106, 110
EnDM (En1-/-En2-/-), 76
EnHT (En1+/-En2-/-), 13, 14, 24, 25, 40, 42,
58, 67, 69, 70, 71, 72, 74, 76, 90, 92, 101,
105, 106, 110
environment, 32, 34, 92
ErbB4, 85
Fgf8, 17, 18, 19, 20, 21, 23, 103, 122, 127
Foxa1 (HNF3α), VI, VIII, 13, 40, 41, 51, 58,
80, 83, 84, 85, 86, 106, 110, 112, 116, 131
gain-of-function, 121
Gbx, 106
GDNF, 26, 106, 112, 115, 130
hindbrain, 15, 16, 17, 19, 20, 21, 23, 26, 76,
79, 102, 113, 121, 123, 128, 131, 132
homeobox, 16, 20, 21, 23, 45, 89, 106, 119
HPLC, 75
innervation, 12, 26, 28, 30, 110, 132
isthmus, 16, 20, 21, 23, 102
JNK, 33, 114
Kir6.1, VI, VIII, 39, 95
Kir6.2, VI, VIII, 14, 39, 41, 42, 96, 99, 100,
106
L-DOPA, 25, 36, 107
Lmx1a, 22, 23
Lmx1b, 22, 23, 58, 89, 102, 110, 111, 114,
116, 128
locus coruleus, 24, 25, 31, 36, 58, 76, 78, 79
midbrain, I, VI, 12, 15, 16, 17, 18, 19, 20, 21,
22, 23, 24, 25, 26, 27, 40, 42, 46, 58, 59,
62, 63, 75, 76, 79, 80, 87, 89, 92, 93, 96,
100, 102, 110, 111, 112, 113, 114, 115,
116, 118, 120, 121, 122, 123, 125, 126,
127, 128, 130, 131, 132
mitochondria, 32, 94, 96, 97, 98, 123, 124, 127
mitochondrial dysfunction, 32
mitochondrial pathway of apoptosis, 101
mKATP, 94, 95, 97, 98, 99, 100, 104, 105, 107,
110
MN9D, 118
motor behaviour, 25
MPTP, 35, 36, 38, 39, 47, 48, 58, 59, 60, 61,
62, 63, 64, 65, 66, 74, 75, 92, 93, 96, 97,
98, 99, 100, 101, 102, 107, 110, 114, 116,
118, 122, 123, 125, 127, 131
neomycin, 45, 85, 86
neurotransmitter, 33, 128
nucleus accumbens, 130
olfactory tubercle, 28
Otx, 107, 111, 128
Parkinson's disease, VI, X, 12, 13, 29, 30, 31,
33, 34, 35, 38, 96, 100, 104, 105, 107, 110
Parkinson's patient, 13, 29, 31
patterning, 17, 19, 116, 121, 122, 123, 125,
132
PC12, 94, 107, 129
Pitx3, 23, 25, 26, 105, 107, 120, 122, 124, 128
pmKATP, 93, 94, 95, 96, 97, 98, 99, 100, 104,
107
postmitotic, 15, 129
precursor cell, 22, 78, 79, 102
raphe nucleus, 76, 79
recombinant mutant mouse, 14
retrorubral field, 28, 107
rhombomere, 78
RNA interference, 23
ROS, 35, 65, 94, 97, 100, 105, 107, 114
rotenone, 35, 37, 38, 39, 47, 58, 59, 60, 61, 62,
63, 64, 65, 67, 92, 93, 94, 96, 97, 98, 99,
101
Index
104
secretion, 18, 20, 38, 110, 114, 127
serotonin, 76, 79, 118, 122
sonic hedgehog, 18, 113, 119, 126
substantia nigra, VI, VIII, 12, 13, 23, 24, 25,
28, 29, 30, 35, 36, 37, 39, 40, 67, 69, 70,
72, 89, 100, 101, 105, 107, 110, 113, 114,
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nigral, 12, 25, 29, 58, 68, 74, 92, 105, 111,
123, 127
Sur1, VI, VIII, 14, 39, 41, 42, 44, 45, 58, 67,
69, 70, 71, 72, 100, 101, 105, 107, 110, 127
survival, VI, 14, 19, 22, 24, 26, 31, 32, 40, 42,
50, 59, 60, 61, 62, 63, 64, 65, 66, 67, 72,
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114, 123
tauLacZ, 78, 108
Tgfβ, 22, 107
transcription factor, VI, 13, 19, 20, 21, 23, 25,
26, 40, 76, 78, 83, 87, 89, 102, 106, 107,
108, 111, 113, 114, 119, 120, 125, 133
tyrosine hydroxylase, VI, 13, 14, 22, 23, 25,
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weight, 48, 75, 129
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